Niveau/ Type |
Code |
Weergavenaam |
Codesysteem |
Omschrijving |
0-L |
1 |
cardiolipine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2 |
acylcarnitine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
3 |
acylcarnitine/carnitine ratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
4 |
angiotensine converting enzyme |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
5 |
acetylcholinesterase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
6 |
acenocoumarol (Sintrom) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
7 |
adrenocorticotroophormoon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
8 |
antidiuretisch hormoon (vasopressine) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
9 |
adrenaline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
10 |
androsteendion |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
11 |
androstanolon (dihydrotestosteron) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
12 |
adenovirus IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
13 |
adenovirus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
14 |
adenovirus IgM as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
15 |
alkalische fosfatase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
16 |
alkalische fosfatase bot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
17 |
alkalische fosfatase intestinaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
18 |
alkalische fosfatase isoenzymen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
19 |
alkalische fosfatase koinozyme |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
20 |
alkalische fosfatase leukocytair |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
21 |
alkalische fosfatase lever |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
22 |
alkalische fosfatase macromolekulair |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
23 |
alkalische fosfatase nier |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
24 |
alfafoetoproteïne |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
25 |
alkalische fosfatase placentair A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
26 |
alkalische fosfatase placentair B |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
27 |
alkalische fosfatase placentair |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
28 |
alkalische fosfatase pseudoplacentair |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
29 |
alkalische fosfatase regan |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
30 |
alkalische fosfatase tumoraal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
31 |
angiotensine II |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
32 |
acid-HAM test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
33 |
aluminium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
34 |
aminolevulinezuur, alfa- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
35 |
alanineaminotransferase (ALAT;SGPT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
36 |
albumine bloed |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
37 |
albumine fractie in EW spectrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
38 |
albumine (micro-) urine portie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
39 |
albumine (micro-) urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
40 |
albumine (micro-) /kreatinine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
41 |
albumine/kreatinine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
42 |
albumine (micro-) /kreatinine urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
43 |
aldolase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
44 |
aldosteron |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
45 |
apolipoproteïne spectrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
46 |
apolipoproteïne A1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
47 |
apolipoproteïne A2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
48 |
apolipoproteïne A1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
49 |
apolipoproteïne B |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
50 |
apolipoproteïne E |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
51 |
amiodaron (Cordarone) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
52 |
amfetamine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
53 |
amfetamine ur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
54 |
amikacine (Amukin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
55 |
ammonium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
56 |
amylase isoenzym P1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
57 |
amylase isoenzym P2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
58 |
amylase isoenzym P3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
59 |
amylase pancreastype |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
60 |
amylase isoenzym S1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
61 |
amylase isoenzym S2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
62 |
amylase isoenzym S3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
63 |
amylase speekselkliertype |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
64 |
amitryptiline (Tryptizol, Sarotex) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
65 |
amylase isoenzymen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
66 |
amylase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
67 |
amylase urine kwal. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
68 |
antinucleaire as. (ANF) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
69 |
androsteron |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
70 |
antinucleaire factor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
71 |
atrial natriuretic peptide |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
72 |
antiperinucleaire factor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
73 |
antiplasmine alfa-2 ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
74 |
antiplasmine alfa-2 activiteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
75 |
activ. partial tromboplastinetijd (APTT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
76 |
arseen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
77 |
aspartaataminotransferase (ASAT;SGOT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
78 |
Aspergillus fumigatus precip. as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
79 |
aspect faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
80 |
aspect sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
81 |
antistreptolysine titer (AST) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
82 |
antitrombine III |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
83 |
antitrombine III ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
84 |
antitrombine III activiteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
85 |
antitrypsine, alfa-1- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
86 |
alfa-1-zuurglycoproteïne |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
87 |
bacteriÎn urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
88 |
soort bacteriÎn (uricult) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
89 |
bacteriÎn in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
90 |
bacteriÎn in urinesediment, gemeten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
91 |
bacteriÎn sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
92 |
base excess (ven) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
93 |
base excess |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
94 |
Bartonella henselae (kattekrab) as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
95 |
Bartonella henselae (kattekrab) as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
96 |
Bartonella henselae (kattekrab) as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
97 |
barbituraten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
98 |
barbituraten kwantitatief |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
99 |
barbituraten ur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
100 |
basofiele granulocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
101 |
basofiele granulocyten, absoluut |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
102 |
aantal bacteriÎn (uricult) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
103 |
beta-caroteen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
104 |
Bence-Jones eiwit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
105 |
bloedgassen (ASTRUP) ven. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
106 |
bloedgassen (ASTRUP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
107 |
bloedgroep rhesus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
108 |
standaard bicarbonaat ven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
109 |
standaard bicarbonaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
110 |
bilirubine direct/geconjugeerd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
111 |
bilirubine totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
112 |
bilirubine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
113 |
bilirubine urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
114 |
bilirubine neonataal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
115 |
blasten ongedifferentieerd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
116 |
bloedingstijd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
117 |
Bordetella pertussis (Toxine) as. IgA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
118 |
Bordetella pertussis (Toxine) as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
119 |
Bordetella pertussis as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
120 |
Bordetella pertussis as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
121 |
bof IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
122 |
bof as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
123 |
bof IgM as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
124 |
as. boompollen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
125 |
Borrelia Burgdorferi as. IgA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
126 |
Borrelia B. confirmation test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
127 |
Borrelia Burgdorferi as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
128 |
Borrelia Burgdorferi as. (Lyme) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
129 |
Borrelia Burgdorferi as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
130 |
Brucella as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
131 |
Brucella as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
132 |
Brucella as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
133 |
bromazepam (Lexotanil) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
134 |
bezinking (BSE) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
135 |
bezinking na 2 uur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
136 |
bezinking microbepaling |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
137 |
benzodiazepine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
138 |
CA 125 tumormarker |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
139 |
CA 15-3 tumormarker |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
140 |
CA 19-1 tumormarker |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
141 |
CA 19-9 tumormarker |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
142 |
CA 125 / CEA ratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
143 |
complement C1-esteraseremmer act. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
144 |
complement C1q |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
145 |
circulerende immuuncomplexen (C1q bind) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
146 |
CA 27-29 tumormarker |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
147 |
complement C3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
148 |
complement C3 nephritic factor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
149 |
complement C4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
150 |
CD4/CD8 lymfocytenverhouding |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
151 |
complement C5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
152 |
calcium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
153 |
calcium urine 24-uurs |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
154 |
calcium urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
155 |
calcium, geïoniseerd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
156 |
kweek Campylobacter jejuni faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
157 |
kweek Candida albicans fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
158 |
cannaboïden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
159 |
complement AP50 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
160 |
carnitine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
161 |
complement-bindingsreactie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
162 |
carbamazepine (Tegretol, Carbymal) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
163 |
carbamazepine-epoxyde |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
164 |
cervixcytologie BVO - indicatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
165 |
cervixcytologie BVO - indicatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
166 |
cervixcytologie BVO - herinn.oproep GGD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
167 |
cervixcytologie BVO - herinn.oproep HA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
168 |
cervixcytologie BVO - oproep GGD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
169 |
cervixcytologie BVO - oproep HA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
170 |
cervixcytologie BVO - vervolgoproep HA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
171 |
CD-transferrine (carbohydraat-deficiÎnt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
172 |
carcinoÎmbryonaal ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
173 |
cefalinetijd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
174 |
complement CH50 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
175 |
Chlamydia trachomatis DNA oogvocht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
176 |
Chlamydia trachomatis DNA urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
177 |
Chlamydia trachomatis DNA uretra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
178 |
Chlamydia trachomatis DNA cervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
179 |
Chlamydia trachomatis DNA fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
180 |
cholinesterase (pseudo-) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
181 |
cholesterol/HDL-cholesterol ratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
182 |
Chlamydia trachomatis as. IgA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
183 |
Chlamydia trachomatis ag. uretra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
184 |
Chlamydia trachomatis ag. cervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
185 |
Chlamydia trachomatis as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
186 |
Chlamydia trachomatis as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
187 |
kweek Chlamydia trachomatis oogvocht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
188 |
kweek Chlamydia trachomatis urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
189 |
kweek Chlamydia trachomatis uretra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
190 |
kweek Chlamydia trachomatis fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
191 |
Chlamydia trachomatis as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
192 |
cholesterol totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
193 |
creatine (fosfo)kinase (CPK) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
194 |
creatine (fosfo)kinase iso MB (CPK-MB) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
195 |
creatine (fosfo)kinase MB massa |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
196 |
chloride |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
197 |
chloride urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
198 |
clobazam (Frisium) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
199 |
clomipramine (Anafranil) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
200 |
clonazepam (Rivotril) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
201 |
ciclosporine (Neoral) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
202 |
clue-cells |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
203 |
clozapine (Leponex) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
204 |
cytomegalievirus as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
205 |
cytomegalievirus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
206 |
cytomegalievirus as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
207 |
kooldioxide totaal ven. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
208 |
kooldioxide totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
209 |
cocaïne |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
210 |
coffeïne |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
211 |
koolmonoxide hemoglobine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
212 |
colloïd-osmotische druk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
213 |
coproporfyrine faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
214 |
coproporfyrine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
215 |
cortisol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
216 |
cortisol urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
217 |
cortisol vrij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
218 |
Coxsackievirus B1 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
219 |
Coxsackievirus B2 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
220 |
Coxsackievirus B3 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
221 |
Coxsackievirus B4 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
222 |
Coxsackievirus B5 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
223 |
Coxsackievirus B6 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
224 |
Coxsackievirus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
225 |
ceruloplasmine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
226 |
C-peptide |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
227 |
C-reactive proteïne (CRP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
228 |
cryoglobulinen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
229 |
calcitonine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
230 |
koper |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
231 |
koper urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
232 |
cylinders urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
233 |
anticytoplasma as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
234 |
fibrine D-dimeer |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
235 |
dubbelstreng-DNA as. (anti ds-DNA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
236 |
doxepine, desmethyl- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
237 |
dehydroÎpiandosteron |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
238 |
dehydroÎpiandosteronsulfaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
239 |
diazepam (Valium) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
240 |
directe Coombs antiglobulinetest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
241 |
leukocyten, differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
242 |
digitoxine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
243 |
digoxine (Lanoxin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
244 |
desipramine (Pertofran) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
245 |
desmethylclomipramine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
246 |
desmethylclobazam |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
247 |
desmethylmaprotiline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
248 |
enkelstreng DNA as. (anti ss-DNA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
249 |
desoxycortisol, 11- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
250 |
desoxycortisol, 9- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
251 |
dopamine (Dynatra) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
252 |
dosulepine, desmethyl- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
253 |
dosulepine (Prothiaden) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
254 |
disopyramide (Rythmodan, Ritmoforine) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
255 |
duif precipiterende as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
256 |
doxepine (Sinequan) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
257 |
erytroblasten, basofiel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
258 |
Epstein-Barrvirus caps.ag. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
259 |
Epstein-Barrvirus caps.ag. as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
260 |
Epstein-Barrvirus caps.ag. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
261 |
Epstein-Barrvirus E-ag. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
262 |
Epstein-Barrvirus E-ag. as |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
263 |
Epstein-Barrvirus E-ag. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
264 |
erytroblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
265 |
erytroblasten, mesochromatisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
266 |
Epstein-Barrvirus, monosticon (EBV) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
267 |
Epstein-Barrvirus nucl.ag. tot. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
268 |
Epstein-Barrvirus nucl.ag. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
269 |
Epstein-Barrvirus nucl.ag. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
270 |
erytroblasten, ortochromatisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
271 |
erytroblasten, polychromatisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
272 |
Epstein-Barrvirus as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
273 |
Epstein-Barrvirus as. totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
274 |
Epstein-Barrvirus as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
275 |
Echinococcen sp. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
276 |
kweek Escherischia coli faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
277 |
endomysium auto-as. IgA (EMA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
278 |
eiwit urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
279 |
eiwit urine 24-uurs |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
280 |
eiwit urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
281 |
extraheerbaar nucleair antigeen as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
282 |
Enterovirus IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
283 |
Enterovirus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
284 |
Enterovirus IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
285 |
eosinofiele granulocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
286 |
eosinofielen totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
287 |
epitheelcellen urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
288 |
epitheelcellen fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
289 |
sperma epitheelcellen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
290 |
erytrocyten, polychromatisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
291 |
erytrocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
292 |
erytrocyten urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
293 |
erytrocyten urine pgv |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
294 |
erytrocyten in urinesediment, gemeten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
295 |
sperma erytrocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
296 |
erytrocyten, doornappel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
297 |
erytrocyten, doornappel in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
298 |
ethanol (alcohol) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
299 |
ethosuximide (Ethymal, Zarontin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
300 |
eiwitspectrum (elektroforese) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
301 |
factor X |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
302 |
factor XI |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
303 |
factor XII |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
304 |
factor XIII |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
305 |
factor II |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
306 |
factor II activiteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
307 |
factor V |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
308 |
factor V Leiden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
309 |
factor V activiteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
310 |
factor VII |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
311 |
factor VII activiteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
312 |
factor VIII |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
313 |
factor VIII-ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
314 |
factor VIII-Cb |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
315 |
factor VIII-C |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
316 |
factor VIII-as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
317 |
factor VIII-Willebrand factor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
318 |
factor IX |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
319 |
factor IX activiteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
320 |
factor Ristocetine cofactor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
321 |
fibrinopeptide A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
322 |
fibrine-degradatieprodukten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
323 |
ijzer |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
324 |
fenylalanine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
325 |
fenobarbital (Luminal) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
326 |
fenytoïne (Diphantoïne) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
327 |
fenytoïne (Diphantoïne) (na injectie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
328 |
ferritine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
329 |
ijzerverzadiging |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
330 |
fibrinogeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
331 |
fluoride |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
332 |
fluvoxamine (Fevarin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
333 |
flunitrazepam, desmethyl- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
334 |
flunitrazepam (Rohypnol) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
335 |
foliumzuur in erytrocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
336 |
foliumzuur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
337 |
fosfaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
338 |
fosfaat (anorg.) urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
339 |
fosfaat urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
340 |
fosfaat urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
341 |
fluoxetine (Prozac) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
342 |
foetoproteïne, alfa-1- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
343 |
fructosamine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
344 |
fructose |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
345 |
fructose in sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
346 |
follikelstimulerend hormoon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
347 |
T3 vrij thyroxine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
348 |
T4 vrij thyroxine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
349 |
lues FTA-abs. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
350 |
thyroxine index, vrije- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
351 |
glucose-6-fosfaatdehydrogenase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
352 |
kweek Gardnerella vaginalis fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
353 |
gastrine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
354 |
glucose dagcurve |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
355 |
glucose dagcurve |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
356 |
gentamicine (Garamycin, Septopal) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
357 |
gewicht patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
358 |
gewicht niersteen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
359 |
gamma-glutamyltransferase (gammaGT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
360 |
groeihormoon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
361 |
globuline, alfa-1- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
362 |
globuline, alfa-2- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
363 |
gliadine IgA as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
364 |
gliadine IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
365 |
Gliadine IgA as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
366 |
globuline, beta- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
367 |
globuline, gamma- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
368 |
glycohemoglobine (HbA1c) DCCT |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
369 |
glad-spierweefsel as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
370 |
glucose tijdstip |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
371 |
glucose niet nuchter |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
372 |
glucose nuchter |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
373 |
glucose T1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
374 |
glucose T2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
375 |
glucose T3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
376 |
glucose T4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
377 |
glucose T5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
378 |
glucose (dagcurve) 2u na diner |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
379 |
glucose (dagcurve) 2u na lunch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
380 |
glucose (dagcurve) 2u na ontbijt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
381 |
glucose niet nuchter, capillair |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
382 |
glucose nuchter, capillair |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
383 |
glucose liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
384 |
glucose urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
385 |
glucose urine kwant |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
386 |
glucose urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
387 |
glucose 24-uurs urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
388 |
glucose urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
389 |
gramneg. coccen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
390 |
gramneg. staven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
391 |
Gonococcen ag. cervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
392 |
Gonococcen ag. as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
393 |
kweek Gonococcen anus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
394 |
kweek Gonococcen oog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
395 |
kweek Gonococcen keel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
396 |
kweek Gonococcen uretra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
397 |
kweek Gonococcen fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
398 |
grampos. coccen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
399 |
grampos. staven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
400 |
grampreparaat keelwat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
401 |
grampreparaat sputum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
402 |
grampreparaat pus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
403 |
grampreparaat urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
404 |
as. graspollen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
405 |
gistcellen fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
406 |
kweek gist huidschilfers |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
407 |
glucose tolerantie test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
408 |
haloperidol (Haldol) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
409 |
hepatitis A as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
410 |
hepatitis A as. tot. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
411 |
hepatitis A as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
412 |
hemoglobine (Hb) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
413 |
hemoglobine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
414 |
hemoglobine urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
415 |
hemoglobine A1c |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
416 |
hemoglobine A1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
417 |
hemoglobine A2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
418 |
hemoglobine C |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
419 |
hepatitis B core ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
420 |
hepatitis B core as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
421 |
hepatitis B core as. tot. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
422 |
hepatitis B core as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
423 |
koolmonoxide hemoglobine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
424 |
hydroxyboterzuurdehydrogenase, 3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
425 |
hemoglobine E |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
426 |
hepatitis B e-ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
427 |
hemoglobine-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
428 |
hepatitis B e-ag. as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
429 |
hemoglobine F |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
430 |
hemoglobine F kwant |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
431 |
methemoglobine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
432 |
hemoglobine S |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
433 |
hepatitis B surf.-ag. (Au-ag) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
434 |
hepatitis B surf.-ag. as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
435 |
hepatitis B confirmation test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
436 |
hemoglobine vrij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
437 |
hemoglobine vrij urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
438 |
humaan choriongonadotropine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
439 |
zwangerschapstest urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
440 |
HCG, beta- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
441 |
hydroxycorticosteron 18- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
442 |
hydroxycorticosteron 18- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
443 |
hepatitis C confirmation test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
444 |
hepatitis C as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
445 |
10-hydroxycarbazepine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
446 |
HDL-cholesterol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
447 |
hemoglobin distribution width |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
448 |
helderheid urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
449 |
hepatitis E confirmation test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
450 |
hepatitis E as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
451 |
hepatitis E as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
452 |
hepatitis E as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
453 |
kwik urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
454 |
HIV-1 ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
455 |
HIV-1 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
456 |
HIV-2 ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
457 |
HIV-2 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
458 |
5-hydroxyindolazijnzuur urine per kreat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
459 |
5-hydroxyindolazijnzuur urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
460 |
HIV core-ag. as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
461 |
HIV env.-ag. as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
462 |
HIV ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
463 |
HIV confirmation test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
464 |
HIV as. (1+2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
465 |
HLA-B27 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
466 |
HLA-B27 confirmation test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
467 |
kweek Haemophilus influenzae keelwat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
468 |
hoeveelheid urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
469 |
hoeveelheid sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
470 |
homocysteïne |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
471 |
homocysteïne, na belasting |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
472 |
as. hond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
473 |
hydroxyprogesteron 17- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
474 |
hydroxyprogesteron 17- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
475 |
haptoglobine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
476 |
hydroxyproline urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
477 |
hydroxyproline urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
478 |
Helicobacter pylori as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
479 |
Helicobacter pylori as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
480 |
Helicobacter pylori as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
481 |
Herpes simplex virus IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
482 |
Herpes simplex virus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
483 |
Herpes simplex virus IgM as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
484 |
hematocriet (Ht) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
485 |
hydroxytryptamine 5- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
486 |
homovanillinezuur urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
487 |
Influenza A as |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
488 |
Influenza B as |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
489 |
immunoglobuline A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
490 |
immunoglobuline A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
491 |
immunoglobuline A as |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
492 |
immunoglobuline D |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
493 |
immunoglobuline E totaal (IgE tot) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
494 |
immunoglobuline G |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
495 |
immunoglobuline G |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
496 |
immunoglobuline G liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
497 |
immunoglobuline G1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
498 |
immunoglobuline G2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
499 |
immunoglobuline G3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
500 |
immunoglobuline G4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
501 |
immunoglobuline G as |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
502 |
immunoglobuline G subklassen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
503 |
immunoglobuline M |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
504 |
immunoglobuline M |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
505 |
immunoglobuline M as |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
506 |
immuno-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
507 |
imipramine (Tofranil) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
508 |
international normalised ratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
509 |
insuline as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
510 |
insuline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
511 |
irregulaire as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
512 |
intrinsieke factor as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
513 |
kalium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
514 |
kalium urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
515 |
as. kat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
516 |
ketonen urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
517 |
kinidine (Cardioquin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
518 |
kleur urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
519 |
koude agglutininen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
520 |
KOH-preparaat nagel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
521 |
KOH-preparaat huid |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
522 |
KOH-preparaat fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
523 |
kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
524 |
kreatinineklaring |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
525 |
kreatinine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
526 |
kreatinine urine 24-uurs |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
527 |
kreatinine urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
528 |
kristallen NNO, urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
529 |
kruisproef |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
530 |
as. kruidpollen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
531 |
ketosteroïden, 17- urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
532 |
ketosteroïden, 17- urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
533 |
lactaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
534 |
lactaatdehydrogenase (LDH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
535 |
LDL/HDL-cholesterol ratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
536 |
LDH isoenzymen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
537 |
LDH iso 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
538 |
LDH iso 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
539 |
LDH iso 3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
540 |
LDH iso 4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
541 |
LDH iso 5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
542 |
LDL-cholesterol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
543 |
Lupus erytematodes-cellen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
544 |
Legionella as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
545 |
kweek Legionella pneumophilia sputum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
546 |
leukocytaire esterase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
547 |
leukocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
548 |
leukocyten urine stick |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
549 |
leukocyten urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
550 |
leukocyten urine pgv |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
551 |
leukocyten in urinesediment, gemeten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
552 |
leukocyten sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
553 |
luteïnizerend hormoon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
554 |
LH-releasing factor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
555 |
lithium (Priadel, Litarex) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
556 |
lidocaïne |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
557 |
lipase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
558 |
lipiden spectrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
559 |
Listeria as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
560 |
lengte patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
561 |
lipoproteïne A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
562 |
lipoproteïne B |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
563 |
lipoproteïne E |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
564 |
lipoproteïne elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
565 |
Leptospira as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
566 |
lorazepam (Temesta) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
567 |
lecithine/sfyngomyelineratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
568 |
large unstained cells |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
569 |
ijzerbindingscapaciteit, latente - |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
570 |
lymfoblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
571 |
lymfocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
572 |
lymfocyten, absoluut |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
573 |
malaria dikke druppel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
574 |
microalbuminurie per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
575 |
microalbuminurie 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
576 |
maprotiline (Ludiomil) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
577 |
mazelen IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
578 |
mazelen as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
579 |
mazelen IgM as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
580 |
M.C.H. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
581 |
M.C.H.C. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
582 |
M.C.V. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
583 |
melanine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
584 |
mestcellen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
585 |
methadon (Symoron) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
586 |
methadon urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
587 |
magnesium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
588 |
microglobuline, beta-2- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
589 |
megaloblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
590 |
megalocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
591 |
megaloblasten, orthochrom. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
592 |
megaloblasten, polychrom. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
593 |
mianserine N-desmethyl- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
594 |
mianserine 8-hydroxy- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
595 |
mianserine (Tolvon) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
596 |
mitochondriÎn as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
597 |
megakaryoblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
598 |
metamyelocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
599 |
mangaan |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
600 |
metanefrines urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
601 |
monoblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
602 |
kweek Moraxella catarrhalis neus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
603 |
monocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
604 |
monocyten, absoluut |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
605 |
sperma perc. motiliteit klasse A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
606 |
sperma perc. motiliteit klasse B |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
607 |
sperma perc. motiliteit klasse C |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
608 |
sperma perc. motiliteit klasse D |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
609 |
Mycoplasma pneumoniae IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
610 |
Mycoplasma pneumoniae as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
611 |
Mycoplasma pneumoniae IgM as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
612 |
sperma percentage licht afwijk. morfol. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
613 |
sperma percentage normale morfologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
614 |
kweek Multi-Res. Staf. aureus urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
615 |
mesuximide (Celontin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
616 |
mesuximide, N-des- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
617 |
kweek Mycob. tuberculosis sputum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
618 |
myeloblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
619 |
myelocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
620 |
myoglobine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
621 |
stikstof totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
622 |
stikstof totaal faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
623 |
stikstof totaal urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
624 |
natrium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
625 |
zweettest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
626 |
natrium urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
627 |
natrium urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
628 |
natrium urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
629 |
natrium urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
630 |
noradrenaline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
631 |
nordazepam (Calmday) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
632 |
neutrofielen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
633 |
neutrofile granulocyten, absoluut |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
634 |
norfluoxetine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
635 |
nikkel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
636 |
nitriet urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
637 |
nitrazepam (Mogadon) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
638 |
normethyldesipramine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
639 |
normetanefrines urine 24 u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
640 |
procaïnamide, N-acetyl- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
641 |
procaïnamide, N-acetyl- |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
642 |
norprothiaden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
643 |
neuron-specifiek enolase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
644 |
nortryptiline (Nortrylen) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
645 |
anisocytose |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
646 |
hypochromasie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
647 |
poikilocytose |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
648 |
polychromasie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
649 |
Howell-Jolly lichaampjes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
650 |
basofiele korreling |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
651 |
schietschijfcellen (target-cells) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
652 |
Cabot ringen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
653 |
elliptocytose (ovalocytose) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
654 |
karyorrhexis |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
655 |
anisochromie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
656 |
grove kernstructuur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
657 |
Burr cells |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
658 |
microplanie/microcytose |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
659 |
macroplanie/macrocytose |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
660 |
blasten NNO |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
661 |
macroscopisch bloed |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
662 |
kristallen, Ca-oxalaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
663 |
kristallen, tripelfosfaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
664 |
kristallen, urinezuur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
665 |
gistcellen urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
666 |
Trichomonas in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
667 |
amorf sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
668 |
uraten, amorf |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
669 |
slijmdraden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
670 |
slijmdraden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
671 |
leukocytenklompjes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
672 |
vetbolletjes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
673 |
spiervezels |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
674 |
zetmeel, onverteerd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
675 |
leukocyten faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
676 |
vetzure naalden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
677 |
wormeieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
678 |
amoeben |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
679 |
Enterobius vermicularis |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
680 |
Taenia saginata |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
681 |
Taenia solium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
682 |
Giardia lamblia |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
683 |
cysten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
684 |
Ankylostoma duodenale |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
685 |
Schistozoma (Bilharzia) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
686 |
grampos. diplococcen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
687 |
gramneg. diplococcen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
688 |
spermatozoÎn |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
689 |
lymfocyten, atypisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
690 |
lymfocyten, geprikkeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
691 |
toxische korreling |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
692 |
Dˆhle lichaampjes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
693 |
hypersegmentatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
694 |
Auer staafjes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
695 |
kernanomalie Pelger Huet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
696 |
lymfocyten, monoachtig |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
697 |
kogelcellen (sferocytose) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
698 |
serum hemolytisch, differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
699 |
sikkelcellen (drepanocyt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
700 |
traandruppelcellen (teardrop) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
701 |
echinocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
702 |
stomatocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
703 |
serum gesluierd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
704 |
serum icterisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
705 |
serum hemolytisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
706 |
serum lipaemisch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
707 |
serum troebel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
708 |
chylomicronen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
709 |
agglutinatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
710 |
kristallen calciumsulfaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
711 |
schizocyten (fragmentocytose) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
712 |
geldrolvorming (pseudoagglut) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
713 |
hypogranulatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
714 |
vacuolen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
715 |
Gumprechtse Schollen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
716 |
macrotrombocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
717 |
vormafwijkingen trombocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
718 |
korrelafwijkingen trombocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
719 |
satellitisme trombocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
720 |
pseudo-Pelger Huet anomalie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
721 |
trombocytenaggregatie - ADP |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
722 |
trombocytenaggregatie - collageen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
723 |
trombocytenaggregatie - ristocetine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
724 |
trombocytenaggregatie - spontaan |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
725 |
hyperchromasie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
726 |
cylinders cel- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
727 |
cylinders hyaline- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
728 |
cylinders korrel- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
729 |
cylinders epitheel- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
730 |
cylinders lipoïddruppel- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
731 |
cylinders was- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
732 |
cylinders erytrocyten- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
733 |
cylinders leukocyten- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
734 |
rondeptiheel in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
735 |
tubulus epitheel in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
736 |
plaveisel epitheel in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
737 |
polymorfe erytrocyten in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
738 |
unimorfe erytrocyten in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
739 |
vet in urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
740 |
zuurstofsaturatie veneus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
741 |
zuurstofsaturatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
742 |
opmerking 1 algemeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
743 |
opmerking 2 algemeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
744 |
opmerking 3 algemeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
745 |
opmerking 4 algemeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
746 |
opmerking 5 algemeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
747 |
opmerking 1 hemoglobine-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
748 |
opmerking 2 hemoglobine-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
749 |
opmerking 3 hemoglobine-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
750 |
occult bloed faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
751 |
occult bloed urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
752 |
opmerking 1 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
753 |
opmerking 2 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
754 |
opmerking 3 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
755 |
opmerking 4 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
756 |
opmerking 5 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
757 |
opmerking 6 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
758 |
opmerking 7 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
759 |
opmerking 8 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
760 |
opmerking 9 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
761 |
opmerking 10 differentiatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
762 |
opmerking 1 eiwitspectrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
763 |
opmerking 2 eiwitspectrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
764 |
opmerking 3 eiwitspectrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
765 |
oestrogeenreceptor in cytosol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
766 |
oestriol totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
767 |
oestron |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
768 |
oestradiol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
769 |
opmerking 1 bij faeces onderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
770 |
opmerking 2 bij faeces onderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
771 |
opmerking 3 bij faeces onderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
772 |
opmerking 1 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
773 |
opmerking 1 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
774 |
opmerking 2 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
775 |
opmerking 2 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
776 |
opmerking 3 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
777 |
opmerking 3 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
778 |
opmerking 4 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
779 |
opmerking 5 hematologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
780 |
opmerking 1 immuno-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
781 |
opmerking 2 immuno-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
782 |
opmerking 3 immuno-elektroforese |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
783 |
opmerking 1 KOH-fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
784 |
opmerking 1 LDH isoenzymen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
785 |
olanzapine (Zyprexa) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
786 |
opiaten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
787 |
opiaten urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
788 |
opmerking 1 RAST |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
789 |
opmerking 2 RAST |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
790 |
opmerking 3 RAST |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
791 |
osmolaliteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
792 |
osmolaliteit faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
793 |
osmolaliteit urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
794 |
osmotische resistentie eryís |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
795 |
osteocalcine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
796 |
opmerking niersteen 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
797 |
opmerking 1 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
798 |
opmerking niersteen 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
799 |
opmerking 2 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
800 |
opmerking niersteen 3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
801 |
opmerking 3 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
802 |
opmerking 4 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
803 |
opmerking 5 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
804 |
opmerking 6 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
805 |
opmerking 7 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
806 |
opmerking 8 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
807 |
opmerking 9 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
808 |
opmerking 10 sediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
809 |
opmerking 1 worm/wormeieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
810 |
opmerking 2 worm/wormeieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
811 |
opmerking 3 worm/wormeieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
812 |
oxalaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
813 |
oxalaat urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
814 |
oxcarbazepine (Trileptal) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
815 |
oxyuren anaalplak |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
816 |
oxazepam (Seresta) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
817 |
opmerking 1 sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
818 |
opmerking 2 sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
819 |
opmerking 3 sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
820 |
Paul-Bunnell |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
821 |
pre-albumine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
822 |
uitstrijkje - PAP - BVO |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
823 |
uitstrijkje - PAP - op indicatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
824 |
uitstrijkje - PAP - zonder indicatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
825 |
uitstrijkje - PAP |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
826 |
uitstrijkje - PAP - wetensch. onderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
827 |
PAP opmerkingen 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
828 |
PAP opmerkingen 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
829 |
PAP opmerkingen 3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
830 |
PAP Andere afwijkingen endometrium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
831 |
PAP Beoordeelbaarheid |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
832 |
PAP Cylinderepitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
833 |
PAP endocervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
834 |
PAP advies |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
835 |
PAP Kwaliteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
836 |
PAP klasse Nicolaou |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
837 |
PAP Ontstekingsverschijnselen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
838 |
PAP Plaveiselepitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
839 |
PAP klasse |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
840 |
pariÎtale cellen as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
841 |
lood |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
842 |
porfobilinogeen urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
843 |
pCO2 koolzuurspanning ven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
844 |
pCO2 koolzuurspanning |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
845 |
platelet distribution width |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
846 |
perfenazine (Trilafon) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
847 |
pH bloed |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
848 |
pH liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
849 |
pH urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
850 |
pH fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
851 |
pH sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
852 |
Multi-rast (Phadiatop) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
853 |
Para-influenza 1 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
854 |
Para-influenza 2 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
855 |
Para-influenza 3 as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
856 |
Para-influenza as. tot. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
857 |
PKU-onderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
858 |
plasmacellen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
859 |
Plasmodium spurium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
860 |
promegaloblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
861 |
plasminogeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
862 |
plasminogeen ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
863 |
plasminogeen activiteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
864 |
promegakaryocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
865 |
promyelocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
866 |
promyelocyten eosinofiel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
867 |
kweek pneumococcen sputum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
868 |
pO2 zuurstofspanning ven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
869 |
pO2 zuurstofspanning |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
870 |
porfyrine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
871 |
porfyrine faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
872 |
porfyrine urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
873 |
porfyrine urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
874 |
pipamperon (Dipiperon) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
875 |
M-proteïnen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
876 |
procaïnamide (3-6h na inn) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
877 |
proteïne C ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
878 |
procaïnamide (Pronestyl) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
879 |
procaïnamide |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
880 |
proteïne C geactiveerd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
881 |
pro-erytroblasten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
882 |
pregnaandiol urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
883 |
pregnaantriol urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
884 |
primidon (Mysoline) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
885 |
promonocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
886 |
progesteron |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
887 |
prolactine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
888 |
protoporfyrine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
889 |
protoporfyrine faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
890 |
protoporfyrine urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
891 |
progesteronreceptor in cytosol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
892 |
proteïne S ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
893 |
protrombine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
894 |
proteïne S vrij ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
895 |
paroxetine (Seroxat) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
896 |
prostaatspecifiek ag. (PSA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
897 |
Psittacosis as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
898 |
Psittacosis as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
899 |
Psittacosis as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
900 |
protrombinetijd (PT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
901 |
prothiaden (dosulepine) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
902 |
parathyroïdhormoon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
903 |
Parvovirus IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
904 |
Parvovirus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
905 |
Parvovirus IgM as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
906 |
as. Dermatophagoidus pteronyssinus d1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
907 |
as. Dermatophagoidus farinae d2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
908 |
as. Dermatophagoidus microceras d3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
909 |
as. Acarus siro (meelmijt) d70 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
910 |
as. Lepidoglyphus destr. d71 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
911 |
as. Tyrophagus putrescentiae d72 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
912 |
as. Glycyphagus domesticus d73 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
913 |
as. huisstof Greer Labs h1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
914 |
as. huisstof Hollister-Stier labs h2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
915 |
as. zijde k64 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
916 |
as. vlasafval k73 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
917 |
as. formaldehyde k80 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
918 |
as. ficus (benjamina/elastica) k81 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
919 |
as. latex (Hevea braziliensis) k82 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
920 |
as. zonnebloemzaad k84 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
921 |
as. reukgras g1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
922 |
as. kropaar g3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
923 |
as. engels raaigras g5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
924 |
as. timotheegras g6 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
925 |
as. reukgras g1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
926 |
as. rogge (gewas) g12 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
927 |
as. witbol g13 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
928 |
as. haver (pollen) g14 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
929 |
as. tarwe (pollen) g15 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
930 |
as. gerst (pollen) g201 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
931 |
as. maïs (pollen) g202 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
932 |
as. esdoorn veder t1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
933 |
as. grauwe els t2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
934 |
as. ruwe berk t3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
935 |
as. hazelaar t4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
936 |
as. beuk t5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
937 |
as. jeneverbes t6 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
938 |
as. eik t7 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
939 |
as. iep t8 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
940 |
as. olijfboom t9 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
941 |
as. notenboom Californische t10 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
942 |
as. plataan t11 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
943 |
as. wilg t12 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
944 |
as. populier t14 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
945 |
as. witte es (vuilboom) t15 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
946 |
as. den Weymouth t16 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
947 |
as. ceder Japanse t17 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
948 |
as. eucalyptus t18 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
949 |
as. mimosa t19 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
950 |
as. mesquite t20 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
951 |
as. melaleuca (cajaput) t21 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
952 |
as. pecanboom t22 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
953 |
as. cypres t23 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
954 |
as. den Australische t73 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
955 |
as. spar t201 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
956 |
as. paardekastanje t203 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
957 |
as. vlierboom t205 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
958 |
as. kastanjeboom t206 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
959 |
as. spar Douglas t207 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
960 |
as. linde t208 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
961 |
as. haagbeuk t209 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
962 |
as. liguster t210 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
963 |
as. amberboom t211 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
964 |
as. ceder t212 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
965 |
as. pinus rabiata (ananas) t213 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
966 |
as. dadelpalm t214 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
967 |
as. ambrosia alsem w1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
968 |
as. ambrosia kale w2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
969 |
as. ambrosia driedelig w3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
970 |
as. ambrosia valse w4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
971 |
as. absinth alsem w5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
972 |
as. bijvoet w6 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
973 |
as. margriet w7 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
974 |
as. paardebloem w8 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
975 |
as. smalle weegbree w9 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
976 |
as. witte of melganzevoet w10 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
977 |
as. loogkruid w11 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
978 |
as. guldenroede w12 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
979 |
as. stekelnoot w13 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
980 |
as. amarant w14 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
981 |
as. melde w15 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
982 |
as. havikskruid w16 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
983 |
as. studentenkruid w17 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
984 |
as. zuring w18 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
985 |
as. glaskruid groot w19 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
986 |
as. brandnetel groot w20 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
987 |
as. glaskruid klein w21 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
988 |
as. koolzaad (raapzaad) w203 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
989 |
as. zonnebloem w204 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
990 |
as. kamille w206 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
991 |
as. lupine w207 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
992 |
as. lycopodium (wolfsklauw) w208 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
993 |
as. suikerbiet w210 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
994 |
as. Penicillium notatum m1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
995 |
as. Cladosporium herbarum m2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
996 |
as. Aspergillus fumigatus m3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
997 |
as. Candida albicans m5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
998 |
as. Alternaria Tenuis m6 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
999 |
as. Botrytus cinerea m7 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1000 |
as. kat e1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1001 |
as. honde-epitheel e2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1002 |
as. paarde-roos e3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1003 |
as. rund roos e4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1004 |
as. hond roos e5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1005 |
as. cavia epitheel e6 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1006 |
as. duif faeces e7 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1007 |
as. kanarieveren e201 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1008 |
as. papegaai veren e213 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1009 |
as. vink veren e214 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1010 |
as. kanarie veren e201 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1011 |
as. rendier epitheel e202 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1012 |
as. nerts (mink) epitheel e203 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1013 |
as. BSA (rund serumalbumine) e204 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1014 |
as. paard serum e205 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1015 |
as. konijn serum e206 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1016 |
as. veren mengsel 2 e207 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1017 |
as. chinchilla e208 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1018 |
as. woestijnrat (gerbil) e209 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1019 |
as. vos epitheel e210 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1020 |
as. konijn urine e211 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1021 |
as. varken urine e212 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1022 |
as. papegaai veren e213 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1023 |
as. vink veren e214 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1024 |
as. duif veren e215 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1025 |
as. hert epitheel e216 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1026 |
as. fret epitheel e217 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1027 |
as. gans veren e70 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1028 |
as. muis epitheel e71 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1029 |
as. muis urineproteïne e72 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1030 |
as. rat epitheel e73 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1031 |
as. rat urineproteïne e74 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1032 |
as. rat serumproteïne e75 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1033 |
as. muis serumproteïne e76 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1034 |
as. parkiet faeces e77 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1035 |
as. parkiet veren e78 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1036 |
as. parkiet serumproteïne e79 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1037 |
as. geit epitheel e80 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1038 |
as. schaap epitheel e81 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1039 |
as. konijn epitheel e82 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1040 |
as. varken epitheel e83 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1041 |
as. hamster epitheel e84 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1042 |
as. kip veren e85 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1043 |
as. eend veren e86 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1044 |
as. rat mengsel e87 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1045 |
as. muis mengsel e88 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1046 |
as. kalkoen veren e89 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1047 |
as. ei-wit f1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1048 |
as. koemelk f2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1049 |
as. kabeljauw f3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1050 |
as. tarwe f4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1051 |
as. rogge (voeding) f5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1052 |
as. gerst f6 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1053 |
as. haver (voeding) f7 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1054 |
as. maïs (voeding) f8 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1055 |
as. rijst f9 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1056 |
as. sesamzaad f10 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1057 |
as. boekweit f11 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1058 |
as. erwt f12 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1059 |
as. pinda f13 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1060 |
as. soja f14 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1061 |
as. boon witte f15 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1062 |
as. hazelnoot f17 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1063 |
as. paranoot f18 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1064 |
as. amandel f20 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1065 |
as. krab f23 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1066 |
as. garnaal f24 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1067 |
as. tomaat f25 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1068 |
as. varkensvlees f26 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1069 |
as. rundvlees f27 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1070 |
as. wortel f31 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1071 |
as. sinaasappel f33 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1072 |
as. aardappel f35 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1073 |
as. kokosnoot f36 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1074 |
as. mossel Zeeuwse f37 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1075 |
as. tonijn f40 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1076 |
as. zalm f41 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1077 |
as. aardbei f44 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1078 |
as. gist f45 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1079 |
as. knoflook f47 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1080 |
as. ui f48 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1081 |
as. appel f49 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1082 |
as. makreel japanse (kopvoorn-) f50 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1083 |
as. bamboescheut f51 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1084 |
as. aardappel zoete f54 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1085 |
as. gierst f55 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1086 |
as. gierst vogel f56 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1087 |
as. hanepoot (Japanse gierst) f57 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1088 |
as. inktvis (Sepia offic.) f58 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1089 |
as. inktvis kraak (Octopus vulg.) f59 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1090 |
as. horsmakreel f60 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1091 |
as. sardine f61 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1092 |
as. eigeel f75 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1093 |
as. lactalbumine-alfa f76 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1094 |
as. lactglobuline-beta f77 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1095 |
as. caseïne f78 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1096 |
as. gluten f79 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1097 |
as. kreeft f80 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1098 |
as. kaas f81 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1099 |
as. kaas schimmel- f82 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1100 |
as. kippevlees f83 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1101 |
as. kiwi f84 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1102 |
as. selderij f85 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1103 |
as. peterselie f86 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1104 |
as. meloen f87 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1105 |
as. lamsvlees f88 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1106 |
as. mosterd f89 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1107 |
as. mout f90 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1108 |
as. mango f91 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1109 |
as. banaan f92 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1110 |
as. cacao f93 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1111 |
as. peer f94 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1112 |
as. perzik f95 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1113 |
as. avocado f96 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1114 |
as. pecannoot f201 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1115 |
as. cashewnoot f202 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1116 |
as. pistachenoot f203 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1117 |
as. forel f204 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1118 |
as. haring f205 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1119 |
as. makreel f206 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1120 |
as. strandgaper (clam) f207 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1121 |
as. citroen f208 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1122 |
as. grapefruit f209 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1123 |
as. ananas f210 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1124 |
as. braam f211 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1125 |
as. champignon f212 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1126 |
as. konijnenvlees f213 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1127 |
as. spinazie f214 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1128 |
as. sla f215 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1129 |
as. kool f216 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1130 |
as. spruitjes brusselse f217 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1131 |
as. paprika f218 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1132 |
as. venkel zaad f219 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1133 |
as. kaneel f220 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1134 |
as. koffie f221 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1135 |
as. thee f222 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1136 |
as. gierst zaad f223 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1137 |
as. papaver zaad f224 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1138 |
as. pompoen f225 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1139 |
as. pompoen zaad f226 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1140 |
as. suikerbiet zaad f227 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1141 |
as. melkpoeder NestlÈ f228 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1142 |
as. melk gekookt f231 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1143 |
as. ovalbumine (kipeiwit) f232 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1144 |
as. ovomucoide (kipeiwit) f233 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1145 |
as. vanille f234 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1146 |
as. linze f235 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1147 |
as. wei f236 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1148 |
as. abrikoos f237 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1149 |
as. kers f242 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1150 |
as. vlees mengsel f243 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1151 |
as. komkommer f244 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1152 |
as. ei-mengsel (dooier en wit) f245 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1153 |
as. guargom (E412) f246 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1154 |
as. honing f247 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1155 |
as. mengsel vis f251 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1156 |
as. pijnboompit f253 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1157 |
as. schol f254 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1158 |
as. pruim f255 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1159 |
as. walnoot f256 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1160 |
as. inktvis pijl- (Loligo vulg.) f258 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1161 |
as. druiven f259 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1162 |
as. broccoli f260 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1163 |
as. asperge f261 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1164 |
as. aubergine f262 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1165 |
as. peper groene f263 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1166 |
as. paling f264 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1167 |
as. karwij f265 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1168 |
as. foelie f266 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1169 |
as. kardemom f267 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1170 |
as. kruidnagel f268 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1171 |
as. basilicum f269 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1172 |
as. gember f270 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1173 |
as. anijs f271 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1174 |
as. dragon f272 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1175 |
as. tijm f273 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1176 |
as. marjolein f274 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1177 |
as. lavas f275 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1178 |
as. venkel f276 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1179 |
as. dille f277 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1180 |
as. laurierblad f278 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1181 |
as. peper chili (spaanse) f279 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1182 |
as. peper zwarte f280 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1183 |
as. kerry f281 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1184 |
as. nootmuskaat f282 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1185 |
as. oregano f283 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1186 |
as. kalkoenvlees f284 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1187 |
as. elandvlees f285 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1188 |
as. paardemelk f286 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1189 |
as. boon rode (red kidneybean) f287 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1190 |
as. bosbes f288 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1191 |
as. dadel f289 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1192 |
as. oester f290 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1193 |
as. bloemkool f291 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1194 |
as. guave f292 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1195 |
as. papaja f293 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1196 |
as. passievrucht f294 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1197 |
as. carambola f295 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1198 |
as. johannesbrood f296 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1199 |
as. arabische gom f297 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1200 |
as. tragacant (hokjespeul) f298 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1201 |
as. kastanje f299 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1202 |
as. geitenmelk f300 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1203 |
as. dadelpruim f301 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1204 |
as. mandarijn f302 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1205 |
as. heilbot f303 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1206 |
as. langoest f304 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1207 |
as. fenegriek f305 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1208 |
as. limoen f306 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1209 |
as. heek europese f307 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1210 |
as. sardine pilchard f308 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1211 |
as. keker (cicer) f309 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1212 |
as. voederwille f310 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1213 |
as. schartong f311 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1214 |
as. zwaardvis f312 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1215 |
as. ansjovis f313 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1216 |
as. slak f314 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1217 |
as. snijboon (groene boon) f315 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1218 |
as. raapsteeltjes mei- (raapzaad) f316 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1219 |
as. koriander f317 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1220 |
as. broodvrucht f318 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1221 |
as. suikerbiet (beetwortel) f319 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1222 |
as. bijegif i1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1223 |
as. wespegif i3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1224 |
as. daas i204 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1225 |
as. horzel i5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1226 |
as. mug i71 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1227 |
as. penicilloyl G c1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1228 |
as. penicilloyl V c2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1229 |
as. insuline varken c70 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1230 |
as. insuline runder c71 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1231 |
as. insuline humaan c73 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1232 |
as. ampicilline c203 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1233 |
as. amoxicilline c204 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1234 |
Quetelet-index (BMI) patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1235 |
as. mengsel boerderij pax1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1236 |
as. mengsel bakkerij pax4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1237 |
as. mengsel graspollen gx1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1238 |
as. mengsel graspollen gx3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1239 |
as. mengsel boompollen tx9 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1240 |
as. mengsel kruidpollen wx3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1241 |
as. mengsel boompollen tx1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1242 |
as. mengsel kruidpollen wx6 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1243 |
as. mengsel kruidpollen wx7 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1244 |
as. mengsel knaagdier epith ex70 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1245 |
as. mengsel voliËre-vogels ex72 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1246 |
as. mengsel veren ex71 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1247 |
as. mengsel schimmels mx1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1248 |
as. mengsel noten 1 fx1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1249 |
as. mengsel zeebanket fx2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1250 |
as. mengsel granen fx3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1251 |
as. mengsel voedsel fx5 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1252 |
as. mengsel pizza fx7 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1253 |
as. mengsel muesli/cruesli fx8 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1254 |
as. mengsel vruchten 2 fx9 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1255 |
as. mengsel vlees uitgebr. fx10 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1256 |
as. mengsel groenten 2 fx11 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1257 |
as. mengsel groenten 3 fx12 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1258 |
as. mengsel groenten 4 fx13 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1259 |
as. mengsel groenten 5 fx14 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1260 |
as. mengsel vruchten 3 fx15 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1261 |
as. mengsel vruchten 4 fx16 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1262 |
as. mengsel vruchten fx17 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1263 |
as. mengsel peulvruchten fx18 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1264 |
as. mengsel groenten fx19 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1265 |
as. mengsel granen 2 fx20 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1266 |
as. mengsel vruchten 5 fx21 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1267 |
as. mengsel noten 2 fx22 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1268 |
as. mengsel vlees f243 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1269 |
as. mengsel specerijen 2 fx71 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1270 |
as. mengsel specerijen 3 fx72 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1271 |
as. kruidenmengsel 1 fx70 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1272 |
Quetelet-index (BMI) patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1273 |
red bloodcell distribution width |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1274 |
reductie in urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1275 |
renine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1276 |
reticulocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1277 |
reticuline vezels auto-as. (ARA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1278 |
reumafactoren kwant |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1279 |
reumafactoren, Waaler-Rose test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1280 |
rhesus as (32e week) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1281 |
rhesusfactor (navelstreng) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1282 |
rhesus as. (32e week) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1283 |
Rotavirus as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1284 |
Rotavirus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1285 |
Rotavirus as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1286 |
risperidon (Risperdal) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1287 |
Resp. syncytieel virus IgG as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1288 |
Resp. syncytieel virus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1289 |
Resp. syncytieel virus IgM as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1290 |
Rubella as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1291 |
Rubella as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1292 |
Rubella as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1293 |
salicylzuur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1294 |
kweek Salmonella typhi faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1295 |
kweek Salmonella/Shigella faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1296 |
schimmeldraden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1297 |
as. schimmels |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1298 |
kweek schimmel haren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1299 |
kweek schimmel nagels |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1300 |
kweek schimmel huid |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1301 |
seleen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1302 |
seleen urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1303 |
urinesediment |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1304 |
segmentkernige neutrofielen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1305 |
serotonine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1306 |
soortelijk gewicht urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1307 |
sperma aantal granulocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1308 |
sex hormoon bindend globuline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1309 |
kweek Shigella faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1310 |
sikkelcel-test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1311 |
sperma aantal kernhoudende cellen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1312 |
somatomedine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1313 |
somatostatine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1314 |
spermatozoÎn, agglutinatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1315 |
spermatozoÎn, abn. kopvorm, % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1316 |
sperma aggregatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1317 |
spermatozoÎn, goed bew., % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1318 |
spermatozoÎn, goed bew. na 1 uur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1319 |
spermatozoÎn, matig bew., % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1320 |
spermatozoÎn, matig bew.na 1 uur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1321 |
spermatozoÎn, niet bew., % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1322 |
spermatozoÎn, niet bew. na 1 uur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1323 |
spermatozoÎn, levende, % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1324 |
sperma-analyse |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1325 |
sperma functionele concentratie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1326 |
sperma auto-antistoffen IgA/MARIgA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1327 |
sperma auto-antistoffen IgG/MARIgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1328 |
spermatozoÎn, voorstadia, % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1329 |
spermatozoÎn, aantal/ml |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1330 |
spermatozoÎn, aantal totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1331 |
kweek bloed |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1332 |
kweek faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1333 |
kweek liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1334 |
kweek keelwat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1335 |
kweek neuswat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1336 |
kweek sputum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1337 |
kweek pus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1338 |
kweek urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1339 |
kweek uretra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1340 |
kweek cervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1341 |
kweek fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1342 |
staafkernige neutrofielen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1343 |
Salmonella typhi BO as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1344 |
Salmonella typhi CO as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1345 |
analyse niersteen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1346 |
Salmonella typhi H as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1347 |
Salmonella typhi O as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1348 |
Schistozoma as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1349 |
sperma VCM waarde |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1350 |
sperma aantal voorstadia |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1351 |
T3 triiodothyronine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1352 |
T4 thyroxine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1353 |
T4/T3 uptake index |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1354 |
thyroïd bindend globuline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1355 |
eiwit totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1356 |
eiwit totaal urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1357 |
temperatuur patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1358 |
testosteron |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1359 |
testosteron vrij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1360 |
transferrine saturatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1361 |
schildklier cytoplasma as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1362 |
theofylline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1363 |
thyreoglobuline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1364 |
thyroïd peroxidase as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1365 |
schildklierweefsel as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1366 |
thallium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1367 |
troponine-I, bloed (TNI) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1368 |
troponine-T, bloed (TNT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1369 |
tobramycine (Obracin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1370 |
Toxoplasma as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1371 |
Toxoplasma as. tot. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1372 |
Toxoplasma as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1373 |
lues TPHA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1374 |
trombocytenaggregatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1375 |
transcobalamine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1376 |
transferrine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1377 |
triglyceriden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1378 |
trombocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1379 |
trombocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1380 |
trombinetijd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1381 |
Trichomonas |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1382 |
kweek Trichomonas vaginalis uretra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1383 |
kweek Trichomonas vaginalis fluor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1384 |
trazodon (Trazolan) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1385 |
thyroïd stimulerend hormoon (TSH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1386 |
TSH (TRH) T0 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1387 |
TSH (TRH) T1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1388 |
TSH (TRH) T2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1389 |
TSH (TRH) T3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1390 |
TSH receptor as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1391 |
TSH/TRH belastingstest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1392 |
trombotest (TT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1393 |
Toxocara canis as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1394 |
ijzerbindingscapaciteit totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1395 |
urobilinogeen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1396 |
ureum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1397 |
ureum urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1398 |
ureum urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1399 |
ureum urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1400 |
uricult (dipslide) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1401 |
urine volledig |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1402 |
urinezuur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1403 |
urinezuur urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1404 |
urinezuur urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1405 |
urobiline urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1406 |
uroporfyrine urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1407 |
uroporfyrine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1408 |
vitamine A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1409 |
valproïnezuur (Depakine) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1410 |
vancomycine (Vancocin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1411 |
vitamine B1 (thiamine) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1412 |
vitamine B12 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1413 |
vitamine B2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1414 |
vitamine B6 (pyridoxine) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1415 |
vitamine C |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1416 |
vitamine D |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1417 |
vitamine D3 (1,25OH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1418 |
lues VDRL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1419 |
vitamine E |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1420 |
faeces vertering |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1421 |
faeces, vet in - |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1422 |
vetzuur faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1423 |
vigabatrine (Sabril) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1424 |
vitamine H |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1425 |
viscositeit plasma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1426 |
viscositeit sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1427 |
VLDL-cholesterol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1428 |
venlafaxine (Efexor) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1429 |
vanilline mandelic acid ur per kreat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1430 |
vanilline mandelic acid urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1431 |
volume urine (portie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1432 |
volume urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1433 |
volume sperma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1434 |
Varicella zoster virus as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1435 |
Varicella zoster virus as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1436 |
Varicella zoster virus as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1437 |
wormen, wormeieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1438 |
ag. bloedgroep A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1439 |
ag. bloedgroep B |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1440 |
ag. bloedgroep Biles |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1441 |
ag. bloedgroep Cartwright |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1442 |
ag. bloedgroep rhesus Ce |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1443 |
ag. bloedgroep Cellano |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1444 |
ag. bloedgroep rhesus C Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1445 |
ag. bloedgroep Chido |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1446 |
ag. bloedgroep rhesus c klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1447 |
ag. bloedgroep Colton a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1448 |
ag. bloedgroep Colton b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1449 |
ag. bloedgroep Cost |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1450 |
ag. bloedgroep rhesus Cw |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1451 |
ag. bloedgroep rhesus D |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1452 |
ag. bloedgroep Diego |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1453 |
ag. bloedgroep Dombrock a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1454 |
ag. bloedgroep Dombrock b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1455 |
ag. bloedgroep rhesus E Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1456 |
ag. bloedgroep rhesus e klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1457 |
Yersinia serologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1458 |
kweek Yersinia enterocolitica faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1459 |
ag. bloedgroep Duffy a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1460 |
ag. bloedgroep Duffy b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1461 |
ag. bloedgroep G |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1462 |
ag. bloedgroep Gerbich |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1463 |
ag. bloedgroep Gregory |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1464 |
ag. bloedgroep H |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1465 |
ag. bloedgroep Holley |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1466 |
ag. bloedgroep I Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1467 |
ag. bloedgroep IH |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1468 |
ag. bloedgroep i klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1469 |
ag. bloedgroep Kidd a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1470 |
ag. bloedgroep Kidd b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1471 |
ag. bloedgroep JMH |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1472 |
ag. bloedgroep Js a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1473 |
ag. bloedgroep Js b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1474 |
ag. bloedgroep Kell Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1475 |
ag. bloedgroep Kell klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1476 |
ag. bloedgroep Kn a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1477 |
ag. bloedgroep Kn b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1478 |
ag. bloedgroep Kp a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1479 |
ag. bloedgroep Kp b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1480 |
ag. bloedgroep Lan |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1481 |
ag. bloedgroep Lewis a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1482 |
ag. bloedgroep Lewis b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1483 |
ag. bloedgroep Leuco |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1484 |
ag. bloedgroep Lutheran a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1485 |
ag. bloedgroep Lutheran b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1486 |
ag. bloedgroep M |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1487 |
ag. bloedgroep McCoy A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1488 |
ag. bloedgroep Mt a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1489 |
ag. bloedgroep N |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1490 |
ag. bloedgroep P1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1491 |
ag. bloedgroep Rodgers |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1492 |
ag. bloedgroep Scianna 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1493 |
ag. bloedgroep Scianna 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1494 |
ag. bloedgroep Sd a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1495 |
ag. bloedgroep S Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1496 |
ag. bloedgroep s klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1497 |
ag. bloedgroep Swann |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1498 |
ag. bloedgroep type 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1499 |
ag. bloedgroep type 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1500 |
ag. bloedgroep type 3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1501 |
ag. bloedgroep typering |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1502 |
ag. bloedgroep Ug |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1503 |
ag. bloedgroep VEL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1504 |
ag. bloedgroep Vg |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1505 |
ag. bloedgroep Wright |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1506 |
ag. bloedgroep Xg a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1507 |
ag. bloedgroep York a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1508 |
as. bloedgroep A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1509 |
as. bloedgroep A1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1510 |
as. bloedgroep A2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1511 |
as. bloedgroep B |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1512 |
as. bloedgroep Biles |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1513 |
as. bloedgroep Cartwright |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1514 |
as. bloedgroep rhesus Ce |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1515 |
as. bloedgroep Cellano |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1516 |
as. bloedgroep rhesus C Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1517 |
as. bloedgroep Chido |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1518 |
as. bloedgroep rhesus c klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1519 |
as. bloedgroep Colton a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1520 |
as. bloedgroep Colton b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1521 |
zuclopentixol (Cisordinol) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1522 |
as. bloedgroep Cost |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1523 |
as. bloedgroep rhesus Cw |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1524 |
as. bloedgroep rhesus D |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1525 |
as. bloedgroep Diego |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1526 |
as. bloedgroep Dombrock a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1527 |
as. bloedgroep Dombrock b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1528 |
as. bloedgroep rhesus E Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1529 |
as. bloedgroep rhesus e klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1530 |
zure fosfatase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1531 |
zure fosfatase, prostaatspecifiek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1532 |
as. bloedgroep Duffy a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1533 |
as. bloedgroep Duffy b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1534 |
as. bloedgroep G |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1535 |
as. bloedgroep Gerbich |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1536 |
as. bloedgroep Gregory |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1537 |
as. bloedgroep H |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1538 |
as. bloedgroep HTLA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1539 |
as. bloedgroep Holley |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1540 |
as. bloedgroep identiteit 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1541 |
as. bloedgroep identiteit 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1542 |
as. bloedgroep identiteit 3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1543 |
as. bloedgroep I Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1544 |
as. bloedgroep IH |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1545 |
as. bloedgroep i klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1546 |
Ziehl-Neelsen preparaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1547 |
as. bloedgroep Kidd a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1548 |
as. bloedgroep Kidd b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1549 |
as. bloedgroep JMH |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1550 |
as. bloedgroep Js a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1551 |
as. bloedgroep Js b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1552 |
as. bloedgroep Kell Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1553 |
as. bloedgroep Kell klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1554 |
as. bloedgroep Kn a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1555 |
as. bloedgroep Kn b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1556 |
as. bloedgroep Kp a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1557 |
as. bloedgroep Kp b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1558 |
as. bloedgroep Lan |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1559 |
as. bloedgroep Lewis a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1560 |
as. bloedgroep Lewis b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1561 |
as. bloedgroep Leuco |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1562 |
as. bloedgroep Lutheran a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1563 |
as. bloedgroep Lutheran b |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1564 |
as. bloedgroep M |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1565 |
as. bloedgroep McCoy A |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1566 |
as. bloedgroep Mt a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1567 |
zink |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1568 |
zink ur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1569 |
as. bloedgroep N |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1570 |
as. bloedgroep koude |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1571 |
as. bloedgroep warmte |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1572 |
as. bloedgroep P1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1573 |
zinkprotoporfyrine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1574 |
as. bloedgroep Rodgers |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1575 |
as. bloedgroep Scianna 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1576 |
as. bloedgroep Scianna 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1577 |
as. bloedgroep Sd a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1578 |
as. bloedgroep S Groot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1579 |
as. bloedgroep s klein |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1580 |
zure steatocriet faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1581 |
as. bloedgroep Swann |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1582 |
as. bloedgroep Us |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1583 |
as. bloedgroep Vel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1584 |
as. bloedgroep Vs |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1585 |
as. bloedgroep Wright |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1586 |
as. bloedgroep Xg a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1587 |
achillespeesreflex linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1588 |
achillespeesreflex rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1589 |
ademhalingsfrequentie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1590 |
allergische klachten luchtwegen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1591 |
alcoholgebruik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1592 |
allergie aangetoond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1593 |
amputatie linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1594 |
amputatie rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1595 |
angineuze klachten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1596 |
angina pectoris (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1597 |
aard van het consult (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1598 |
diagnose astma gesteld door |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1599 |
streefdoelen (1 consult) astma gehaald |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1600 |
beperkt in deur uit gaan (RIQ-B5) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1601 |
evaluatie (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1602 |
diagnose astma eerder gesteld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1603 |
gem. score functionele beperkingen(RIQB) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1604 |
beperkt in uitv. gewone bezigh. (RIQ-B1) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1605 |
aspecifieke hyperreactiviteit luchtwegen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1606 |
gemiddelde score hinder (RIQ-A) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1607 |
astmaklachten uitgelokt door inspanning |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1608 |
inhalatietechniek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1609 |
beperkt in kussen/knuffelen (RIQ-B4) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1610 |
hinder en beperkingen astma/COPD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1611 |
aanvullende geg. longfunctieonderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1612 |
aanvullende geg. anamnese/onderz.(astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1613 |
plan (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1614 |
piekert over ademhaling (RIQ-A4) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1615 |
beperkt in traplopen (RIQ-B2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1617 |
astma in voorgeschiedenis |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1618 |
therapietrouw medicatie (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1619 |
thuisverzuim (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1620 |
vervolgconsult astma/COPD bij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1621 |
vermijden uitlokkende factoren (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1622 |
school-/werkverzuim(astma)%v.aanstelling |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1623 |
beperkt in winkelen (RIQ-B3) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1624 |
wakker door ademproblemen (RIQ-A3) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1625 |
atopische aandoeningen in familie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1626 |
atopische aandoeningen in voorgeschied. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1627 |
bewegelijkheid linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1628 |
bewegelijkheid rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1629 |
cataract linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1630 |
cataract rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1631 |
claudicatio intermittens (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1632 |
claudicatio klachten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1633 |
therapietrouw medicatie (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1634 |
coron HZ in naaste familie <60jr |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1636 |
CVA (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1637 |
opvolgen voedingsadvies (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1638 |
datum laatste fundoscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1639 |
datum bezoek diÎtist insulinegebruik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1640 |
datum bezoek diabetes verpleegkundige |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1641 |
doorbloeding linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1642 |
doorbloeding rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1643 |
decompensatio cordis (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1644 |
tekenen v. decompensatio cordis (anamn) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1645 |
diagnose DM2 gesteld door |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1646 |
evaluatie (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1647 |
diagnose DM2 eerder gesteld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1648 |
DM2 bij naaste familie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1649 |
diabetes-gerelateerde klachten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1650 |
aanvullende geg. anamnese/onderzoek(DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1651 |
(aanvullende gegevens) plan (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1652 |
diabetische retinopathie linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1653 |
diabetische retinopathie rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1654 |
DM2 bestaat (vermoedelijk) sinds |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1655 |
opmerkingen zelfcontrole diabetes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1656 |
zelfcontrole diabetes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1657 |
drukplekken linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1658 |
drukplekken rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1659 |
kortademigheid (anamnese) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1660 |
enkel/armindex links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1661 |
enkel/armindex rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1662 |
overmatige eeltvorming linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1663 |
overmatige eeltvorming rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1664 |
diagnost.steroïdtest: effect op klachten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1665 |
expositie allergenen en aspec. prikkels |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1666 |
frequentie gebruik bronchusverwijders |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1667 |
freq. gebruik bronchusverwijders per dag |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1668 |
frequentie kortademigheid en/of piepen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1669 |
FEV1 voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1670 |
FEV1 personal best |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1671 |
FEV1 personal best % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1672 |
FVC prÈ-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1673 |
FVC prÈ-BD % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1674 |
FVC voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1675 |
FEV1/FVC ratio prÈ-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1676 |
FEV1/FVC voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1677 |
FEV1 post-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1678 |
FEV1 post-BD % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1679 |
FEV1 post-steroïd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1680 |
FEV1 post-steroïd % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1681 |
FEV1 prÈ-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1682 |
FEV1 prÈ-BD % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1683 |
FEV1 prÈ-steroïd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1684 |
FEV1 prÈ-steroïd % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1685 |
FEV1 reversibiliteit post-steroïd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1686 |
FEV1 reversibiliteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1687 |
gebruik hulpademhalingsspieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1688 |
huidatrofie linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1689 |
huidatrofie rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1690 |
histaminedrempel (longinhalatie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1691 |
specifieke hobby's (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1692 |
hoesten (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1693 |
doorgemaakt hartinfarct (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1694 |
hypertensie (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1695 |
infecties linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1696 |
infecties rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1697 |
inspectie linkervoet (diabetes) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1698 |
inspectie rechtervoet (diabetes) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1699 |
klachten en vragen patiënt (diabetes) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1700 |
kleur linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1701 |
kleur rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1702 |
kop-punt discriminatie linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1703 |
kop-punt discriminatie rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1704 |
conclusie longfunctieonderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1705 |
lichaamsbeweging |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1706 |
longfunctiemeting betrouwbaar |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1707 |
frequente luchtweginfecties als kind |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1708 |
mate van dyspnoe |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1709 |
medicatie (DM2) wijzigen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1710 |
monofilamentenonderzoek linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1711 |
monofilamentenonderzoek rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1712 |
kan moeilijk inademen (RIQ-A1) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1713 |
motivatiefase stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1714 |
nachtelijke klachten (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1715 |
naam betrokken specialist (diabetes) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1716 |
oorzaak niet halen streefdoel astma:rest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1717 |
mogelijke oorzaak exacerbatie astma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1718 |
ongeduldig/prikkelbaar (RIQ-A5) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1719 |
rookhistorie (pakjaren) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1720 |
piepende ademhaling (hinderscore RIQ-A2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1721 |
pulsaties a. dorsalis pedis linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1722 |
pulsaties a. dorsalis pedis rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1723 |
PEF avond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1724 |
PEF ochtend |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1725 |
PEF personal best |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1726 |
PEF post-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1727 |
PEF prÈ-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1728 |
PEF reversibiliteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1729 |
conclusie dag-/nachtvariabiliteit PEF |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1730 |
PEF variabiliteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1731 |
pat kan zelf bloedsuikers controleren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1732 |
piepende ademhaling (anamnese) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1733 |
pat kan zelf doseringschema aanpassen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1734 |
spuittechniek (insuline) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1735 |
pulsaties a. tibialis post. linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1736 |
pulsaties a. tibialis post. rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1737 |
ras patiënt (tbv longfunctie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1739 |
roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1740 |
diastolische bloeddruk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1741 |
diastolische bloeddruk (liggend) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1742 |
systolische bloeddruk enkel li (Doppler) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1743 |
systolische bloeddruk enkel re (Doppler) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1744 |
systolische bloeddruk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1745 |
systolische bloeddruk (liggend) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1746 |
klachten en vragen patiënt (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1747 |
standsafwijking linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1748 |
standsafwijking rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1749 |
sensibiliteitsstoornis benen (anamnese) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1750 |
sensibiliteit linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1751 |
sensibiliteit rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1752 |
seksuele stoornissen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1753 |
spuitplekken (diabetes) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1754 |
moeite met uitspreken zin (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1755 |
reacties allergen.+aspec.prikkels(anamn) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1756 |
TIA (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1757 |
ulcera linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1758 |
ulcera rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1759 |
vetstofwisselingsstoornis(comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1760 |
visusklachten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1761 |
visus zonder correctie, linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1762 |
visus zonder correctie, rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1764 |
voedingsgewoontes besproken (diabetes) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1765 |
verschijnselen hypoglycaemie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1766 |
verschijnselen hyperglycaemie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1768 |
aanrakingszin watje linkervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1769 |
aanrakingszin watje rechtervoet |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1770 |
betrokken internist (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1771 |
aard van het consult (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1772 |
aanvul.geg. anamnese/onderz.(astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1773 |
(aanvullende gegevens) evaluatie (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1774 |
(aanvullende gegevens) plan (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1775 |
controlebeleid DM2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1776 |
controlebeleid astma-patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1777 |
aanvullende geg. anamnese/onderz. (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1778 |
streefdoelen (1 consult) COPD gehaald |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1779 |
therapietrouw medicatie (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1780 |
(aanvullende gegevens) evaluatie (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1781 |
(aanvullende gegevens) plan (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1782 |
aard van het consult (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1783 |
startdatum controle/exacerbatie(astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1784 |
startdatum controle/exacerbatie (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1785 |
controlebeleid COPD-patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1786 |
mogelijke oorzaak exacerbatie COPD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1787 |
vervolgconsult COPD bij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1788 |
reden geen geregelde zorg (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1789 |
reden geen geregelde zorg (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1793 |
startdatum controle (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1794 |
systolische bloeddruk bovenarm (Doppler) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1795 |
naam insulinepreparaat ochtend |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1796 |
naam insulinepreparaat middag |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1797 |
naam insulinepreparaat avond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1798 |
naam insulinepreparaat nacht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1799 |
aantal eenheden insuline ochtend |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1800 |
aantal eenheden insuline middag |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1801 |
aantal eenheden insuline avond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1802 |
aantal eenheden insuline nacht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1803 |
complex insulineschema |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1804 |
verzuim in afgelopen 3 mndn (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1805 |
aantal dagen werk/school per week |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1806 |
medicatie (astma) wijzigen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1807 |
medicatie (COPD) wijzigen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1808 |
termijn vervolgconsult (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1809 |
termijn vervolgconsult (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1810 |
termijn vervolgconsult (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1811 |
soort medicatie (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1812 |
advies gewichtsreductie gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1813 |
advies voeding (DM2) gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1814 |
advies stoppen met roken gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1815 |
advies griepvaccinatie gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1816 |
advies lichaamsbeweging gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1817 |
vervolgconsult DM2 bij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1818 |
reden geen geregelde zorg (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1819 |
glucose streefwaarde |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1820 |
gewicht bij QI=27 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1821 |
haalbaar streefgewicht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1822 |
ernst astma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1823 |
overige relevante comorbiditeit (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1824 |
zelfcontrole en -behandeling (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1825 |
advies sanering slaapkamer/huis gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1826 |
afspraken zelfcontr./-behandeling(astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1827 |
reden verwijzing (astma/COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1828 |
reden verwijzing (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1829 |
reden verwijzing (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1830 |
bijwerkingen medicatie (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1831 |
bijwerkingen medicatie (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1832 |
bijwerkingen medicatie (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1833 |
verwijzing longarts (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1834 |
verwijzing longarts (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1835 |
verwijzing kinderarts (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1837 |
verwijzing arbodienst (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1838 |
verwijzing arbodienst (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1839 |
verwijzing longfunctielab. (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1840 |
verwijzing longfunctielaboratorium(COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1841 |
verwijzing longverpleegkundige (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1842 |
verwijzing longverpleegkundige (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1843 |
verwijzing praktijkondersteuner (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1844 |
verwijzing praktijkondersteuner (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1845 |
verwijzing praktijkondersteuner (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1846 |
verwijzing thuiszorg (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1847 |
verwijzing thuiszorg (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1848 |
verwijzing thuiszorg (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1849 |
verwijzing internist (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1850 |
verwijzing diabetesverpleegkundige (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1851 |
termijn follow-up oogonderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1852 |
arm bloeddrukmeting |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1853 |
recidiverend langdurig hoesten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1854 |
chronisch hoesten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1855 |
gesaneerd op huisstofmijt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1856 |
gesaneerd op roken binnenshuis |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1857 |
gesaneerd op huisdieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1858 |
gesaneerd op (overige) aspec. prikkels |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1859 |
opmerkingen sanering |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1861 |
beroep |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1862 |
opmerkingen voetonderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1863 |
diagnose COPD eerder gesteld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1864 |
FVC post-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1865 |
FVC post-BD % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1866 |
FEV1/FVC ratio post-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1867 |
longaandoeningen in naaste familie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1868 |
auscultatie longen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1869 |
as. bloedgroep York a |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1870 |
borstomvang (bij inspiratie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1871 |
borstomvang (bij exspiratie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1872 |
buikomvang (middelomtrek) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1873 |
heupomvang |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1874 |
schedelomtrek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1875 |
polsfrequentie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1876 |
diabetes mellitus type 2 (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1877 |
astma (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1878 |
COPD (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1879 |
overgewicht (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1881 |
oogboldruk links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1882 |
oogboldruk rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1883 |
zwangerschapsduur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1884 |
aantal zwangerschappen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1885 |
aantal bevallingen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1886 |
aantal kinderen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1887 |
datum laatste menstruatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1888 |
datum ‡ terme |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1893 |
visus met correctie, linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1894 |
visus met correctie, rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1895 |
visus met correctie, beide ogen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1896 |
visus zonder correctie, beide ogen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1897 |
X-thorax |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1898 |
longcarcinoom (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1899 |
FVC post-steroïd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1900 |
FVC prÈ-steroïd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1901 |
FVC post-steroïd % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1902 |
FVC prÈ-steroïd % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1903 |
FEV1/FVC ratio prÈ-steroïd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1904 |
FEV1/FVC ratio post-steroïd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1907 |
verzuim in afgelopen 3 maanden (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1908 |
thuisverzuim (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1909 |
oorzaak niet halen streefdoel COPD: rest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1910 |
werkverzuim (COPD) % van aanstelling |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1911 |
diagnose COPD gesteld door |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1912 |
temperatuur patiënt (rectaal gemeten) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1913 |
temperatuur patiënt (in oor gemeten) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1914 |
temperatuur patiënt (axillair gemeten) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1915 |
temperatuur patiënt (oraal gemeten) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1916 |
hemoglobine D |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1917 |
HIV-p24 ag. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1918 |
kreatinineklaring vlgns Cockcroft |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1919 |
kreatinineklaring MDRD formule (GFR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1920 |
glomerulaire filtratie ratio (GFR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1921 |
prostaatspec. ag. complex (PSA complex) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1922 |
vrij PSA / totaal PSA ratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1923 |
pH faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1924 |
eilandjes van Langerhans as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1925 |
bijnierschors as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1926 |
antitrypsine, alfa-1- in faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1927 |
factor II mutatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1928 |
Histonen as. (anti histon) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1929 |
sm as. (anti Smith, anti sm) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1930 |
nucleair RNP as. (anti n.RNP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1931 |
SS-A as. (anti-Ro, anti SS-A) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1932 |
SS-B as. (anti-La, anti SS-B) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1933 |
centromeren as. (anti ACA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1934 |
Scl 70 as. (anti Scl 70) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1935 |
Jo 1 as. (anti Jo 1) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1936 |
lysozym |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1937 |
lysozym urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1938 |
lysozym faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1939 |
lysozym liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1940 |
eiwitspectrum (elektroforese) urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1941 |
globuline, alfa-1- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1942 |
globuline, alfa-2- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1943 |
globuline, beta- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1944 |
globuline, gamma- urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1945 |
opmerking 1 eiwitspectrum urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1946 |
opmerking 2 eiwitspectrum urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1947 |
opmerking 3 eiwitspectrum urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1948 |
albumine fractie in EW spectrum urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1949 |
M-proteïnen urine (vh Bence Jones ew) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1950 |
eiwitspectrum (elektroforese) liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1951 |
opmerking 1 eiwitspectrum liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1952 |
opmerking 2 eiwitspectrum liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1953 |
opmerking 3 eiwitspectrum liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1954 |
globuline, alfa-1- liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1955 |
globuline, alfa-2- liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1956 |
albumine fractie in EW spectrum liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1957 |
pre-albumine liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1958 |
globuline, beta- liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1959 |
globuline, gamma- liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1960 |
M-proteïnen liquor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1961 |
chylomicronen (lipiden spectrum) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1962 |
pre-beta-lipoproteïnen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1963 |
broad-beta-lipoproteïnen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1964 |
beta-lipoproteïnen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1965 |
alfa-lipoproteïnen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1966 |
brain natriuretic peptide (BNP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1967 |
pro brain natriuretic peptide (BNP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1968 |
NTpro brain natriuretic pept. (NTProBNP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1969 |
Campylobacter serologie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1970 |
kwik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1971 |
cyclosporine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1972 |
cadmium |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1973 |
pyridoxal 5 fosfaat (PLP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1974 |
desethylamiodaron |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1975 |
lamotrigine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1976 |
temazepam |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1977 |
tobramycine top |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1978 |
tobramycine dal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1979 |
gentamicine top |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1980 |
gentamicine dal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1981 |
hepatitis-C viral-RNA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1982 |
homovanillinezuur (HVA) urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1983 |
rapid plasma reagine (RPR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1984 |
Gonococcen ag. urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1985 |
waterstofgas uitademingslucht (H2-Ademt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1986 |
catecholaminen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1987 |
catecholaminen urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1988 |
adrenaline urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1989 |
noradrenaline urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1990 |
APC ratio (resistentie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1991 |
aantal jaren gerookt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1992 |
aantal (shag)sigaretten per dag |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1993 |
aantal sigaren per dag |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1996 |
wil op korte termijn stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1997 |
aantal stoppogingen (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
1999 |
reden mislukken eerdere stoppoging(en) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2000 |
nicotinevervangers bij stoppen gebruikt? |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2001 |
stopafspraak gemaakt (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2002 |
afgesproken stopdatum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2003 |
gestopt met roken sinds |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2004 |
advies nicotinevervangende middelen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2005 |
voorschrift bupropion/nortriptyl.(roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2006 |
verwijzing/behandeling elders (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2007 |
reden terugval/niet stoppen (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2008 |
problemen gerelateerd aan stoppen(roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2009 |
redenen patiënt om te stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2010 |
andere barriËres om te stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2011 |
barriËres om te stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2013 |
andere redenen om te stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2014 |
aantal pijpen roken per dag |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2015 |
bijwerkingen medicatie(stoppen m roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2016 |
uitgereikte informatie stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2017 |
vorm van behandeling (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2018 |
aanvullende gegevens rookstatus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2019 |
termijn vervolgconsult (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2020 |
voorschrift andere medicatie (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2021 |
aanvullende gegevens stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2023 |
andere reden gebrek stopmotivatie(roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2025 |
specificatie longaandoeningen in familie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2026 |
afwijkingen auscultatie longen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2027 |
vervolgconsult over roken bij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2030 |
zwangerschap (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2033 |
overige afspraken stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2034 |
verwijzing stop-roken poli |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2035 |
verwijzing groepscursus (stop roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2036 |
verwijzing Stivoro |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2037 |
verwijzing gedragstherapeut (stop roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2038 |
inschakelen zorg/verwijz. overig (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2039 |
afspraak follow-up (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2040 |
soort tabak |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2042 |
atherotrombot. hart-/vaatziekte (comorb) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2043 |
overige relevante omstandigheden (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2045 |
pilgebruik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2046 |
opmerkingen leefstijl |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2047 |
aard van het consult (roken) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2048 |
PAP probleemtypering beoordeelbaarheid |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2049 |
(doorgemaakt) aneurysma aortae (comorb) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2050 |
coronairsclerose (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2051 |
overige atherosclerotische comorbiditeit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2052 |
perifeer arterieel vaatlijden (comorb) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2053 |
hypercholesterolemie (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2054 |
familiaire hypercholesterolemie (comorb) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2055 |
systolische bloeddruk (thuismeting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2056 |
diastolische bloeddruk (thuismeting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2057 |
evaluatie (preventie HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2058 |
(aanvullende geg.) plan (preventie HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2059 |
schildklierdiagn. (TSH zonodig vrij T4) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2060 |
auscultatie hart |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2061 |
afwijkingen auscultatie hart |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2062 |
plaats puntstoot hart (ictus cordis) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2063 |
inschakelen zorg/verwijzing (prev. HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2064 |
bloeddrukverhogende voeding/medicatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2066 |
spermatozoÎn, goed bew. na 1 uur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2067 |
spermatozoÎn, matig bew.na 1 uur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2068 |
spermatozoÎn, niet bew. na 1 uur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2069 |
FEV1 post-steroïd post-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2070 |
FEV1 post-steroïd post-BD % v.voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2071 |
FEV1 reversibiliteit post-steroïd postBD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2072 |
FEV1/FVC ratio post-steroïd post-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2073 |
visus met stenopeïsche opening,linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2074 |
visus met stenopeïsche opening,recht.oog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2075 |
visus met +0,5 lens, linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2076 |
visus met -0,5 lens, linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2077 |
visus met +0,5 lens, rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2078 |
visus met -0,5 lens, rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2079 |
visusbepaling Amslerkaart, linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2080 |
visusbepaling Amslerkaart, rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2081 |
gezichtsveld, rechteroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2082 |
gezichtsveld, linkeroog |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2083 |
audiogram |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2084 |
audiogram, waarde bij 125 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2085 |
audiogram, waarde bij 250 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2086 |
audiogram, waarde bij 500 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2087 |
audiogram, waarde bij 1000 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2088 |
audiogram, waarde bij 2000 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2089 |
audiogram, waarde bij 3000 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2090 |
audiogram, waarde bij 4000 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2091 |
audiogram, waarde bij 6000 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2092 |
audiogram, waarde bij 8000 Hz, linkeroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2093 |
audiogram, waarde bij 125 Hz, rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2094 |
audiogram, waarde bij 250 Hz, rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2095 |
audiogram, waarde bij 500 Hz, rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2096 |
audiogram, waarde bij 1000 Hz,rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2097 |
audiogram, waarde bij 2000 Hz,rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2098 |
audiogram, waarde bij 3000 Hz,rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2099 |
audiogram, waarde bij 4000 Hz,rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2100 |
audiogram, waarde bij 6000 Hz,rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2101 |
audiogram, waarde bij 8000 Hz,rechteroor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2102 |
polsritme |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2103 |
polskwaliteit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2104 |
polskracht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2105 |
FVC post-steroïd post-BD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2106 |
FVC post-steroïd post-BD % van voorspeld |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2107 |
Helicobacter pylori ag. faeces (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2108 |
Gonococcen wattenstok cervix (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2109 |
Gonococcen ag. urine (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2110 |
Chlamydia trach. wattenstok cervix (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2111 |
Bordetella Pertussis (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2112 |
Herpes (genitalis) (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2113 |
kweek Herpes (genitalis) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2114 |
anticyclic citrullin. peptide (anti-CCP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2115 |
bilirubine indirect/ongeconjugeerd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2116 |
kweek nasopharynx |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2117 |
antitissue transglut. as. (anti TTG IgA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2118 |
lymfocyten, grumulee patroon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2119 |
staafkernige neutrofielen totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2120 |
segmentkernige neutrofielen totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2121 |
promyelocyten totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2122 |
myelocyten totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2123 |
metamyelocyten totaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2124 |
vrij PSA / totaal PSA ratio |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2125 |
Chlamydia trachomatis vaginale wat (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2126 |
pols opmerkingen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2127 |
opmerkingen afwijkende Amslertest, links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2128 |
opmerkingen afwijkende Amslertest,rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2129 |
fundusfoto |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2130 |
13C ureum ademtest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2131 |
hart-/vaatziekte in naaste familie <60jr |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2132 |
doorgemaakt herseninfarct(comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2133 |
inschakelen zorg/verwijzing astma/COPD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2134 |
klachten, vragen patiënt (preventie HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2135 |
bijwerkingen medicatie (preventie HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2136 |
medicatie (preventie HVZ) wijzigen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2137 |
advies gezonde voeding gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2138 |
opmerk. bijzonderheden voedingspatroon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2139 |
inschakelen zorg/verwijz. stoppen roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2140 |
inschakelen zorg/verwijzing COPD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2141 |
inschakelen zorg/verwijzing DM2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2142 |
sperma-onderzoek: tijdstip lozing |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2143 |
sperma-onderzoek:aantal dagen onthouding |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2144 |
spermatozoÎn, abn. nek/middenstuk, % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2145 |
spermatozoÎn, abn. staart, % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2146 |
spermatozoÎn, cytoplasmadroplet, % |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2147 |
spermatozoÎn, TZI index |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2148 |
antitissue transglut. as. (anti TTG IgG) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2149 |
vitamine D in navelstrengbloed |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2150 |
glucose (dagcurve) voor de nacht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2151 |
glucose (dagcurve) voor de lunch |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2152 |
glucose (dagcurve) voor het diner |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2153 |
reumafactoren (IgM ELISA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2154 |
reumafactoren, Latex fixatie test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2155 |
Gonococcen ag. uretra (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2156 |
familiaire hypercholesterolemie in fam. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2157 |
vrij prostaatspec. ag. (vrij PSA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2158 |
antistreptodornase |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2159 |
adenovirus ag. faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2160 |
Rotavirus ag. faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2161 |
Chlamydia trachomatis ag. oogvocht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2162 |
Herpes simplex type 1 ag. cervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2163 |
Herpes simplex type 2 ag. cervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2164 |
Influenza A ag. sputum/nasoph. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2165 |
Influenza B ag. sputum/nasoph. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2166 |
Resp. syncytieel virus ag. sputum/nasoph |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2167 |
Borrelia Burgdorferi C6 proteïne |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2168 |
Chlamydia pneumoniae as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2169 |
Chlamydia trachomatis ag. anus (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2170 |
botdichtheid (DEXA) T-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2171 |
botdichtheid (DEXA) Z-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2172 |
Chlamydia trachomatis ag. keel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2173 |
Chlamydia trachomatis ag. anus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2174 |
Gonococcen ag. uretra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2175 |
Gonococcen ag. keel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2176 |
Gonococcen ag. anus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2177 |
Bordetella pertussis FMA as. IgA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2178 |
Bordetella pertussis FMA as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2179 |
nitriet urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2180 |
pH urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2181 |
urobiline urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2182 |
bloed urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2183 |
soortelijk gewicht urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2184 |
Helicobacter pylori ag. faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2185 |
leukocyten urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2186 |
botdichtheidsmeting (DEXA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2187 |
zwangerschapstest urine (stick) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2188 |
diastolische bloeddruk (staand) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2189 |
systolische bloeddruk (staand) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2190 |
anemiediagnostiek (Hb+MCV+zonodig meer) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2191 |
UWIdiagn. (nitriet, bij neg. sedi/dipsl) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2192 |
voedselallergiediagn. (zonodig uitsplit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2193 |
XTC (MDMA) in urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2194 |
(micro)albuminurie (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2195 |
opvolgen bewegingsadvies |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2196 |
risico voetulcera |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2197 |
tekenen van autonome neuropathie (anamn) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2198 |
therapietrouw medicatie (preventie HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2199 |
opvolgen voedingsadvies (prev. HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2200 |
reden verwijzing (preventie HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2201 |
cyclusduur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2202 |
ECG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2203 |
doorgemaakt voetulcus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2204 |
nierfunctiestoornis (comorbiditeit) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2205 |
linkerventrikelhypertrofie (comorb) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2206 |
hoofdbehandelaar diabetes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2207 |
termijn vervolgconsult (preventie HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2208 |
vervolgconsult preventie HVZ bij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2209 |
ernst/stadium COPD (GOLD classificatie) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2210 |
mate van dyspnoe (MRC-schaal) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2211 |
plaatjesfunctie-analyse (PFA) coll/epi |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2212 |
plaatjesfunctie-analyse (PFA) coll/ADP |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2213 |
amylase in urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2214 |
amylase urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2215 |
botdichtheid (DEXA) T-score lwk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2216 |
botdichtheid (DEXA) T-score heup |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2217 |
botdichtheid (DEXA) T-score arm |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2218 |
botdichtheid (DEXA) Z-score lwk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2219 |
botdichtheid (DEXA) Z-score heup |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2220 |
botdichtheid (DEXA) Z-score arm |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2221 |
Strongyloides as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2222 |
kweek Clostridium difficile faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2223 |
risico HVZ volgens CVRM richtlijn |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2224 |
Trichomonas vag. wattenstok cervix (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2225 |
Trichomonas vag. wattenst.uretra (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2226 |
Borrelia Burgdorf. as. IgG (Westernblot) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2227 |
Borrelia Burgdorf. as. IgM (Westernblot) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2228 |
Clostridium difficile toxine A faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2229 |
Clostridium difficile toxine B faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2230 |
Clostridium difficile toxine A+B faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2231 |
Trypanosoma cruzi as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2232 |
nadere determinatie parasitologie (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2233 |
X-bovenarm links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2234 |
X-bovenarm rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2235 |
X-onderarm links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2236 |
X-onderarm rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2237 |
X-elleboog links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2238 |
X-elleboog rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2239 |
X-pols links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2240 |
X-pols rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2241 |
X-schouder links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2242 |
X-schouder rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2243 |
X-hand links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2244 |
X-hand rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2245 |
X-bovenbeen links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2246 |
X-bovenbeen rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2247 |
X-onderbeen links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2248 |
X-onderbeen rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2249 |
X-knie links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2250 |
X-knie rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2251 |
X-enkel links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2252 |
X-enkel rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2253 |
X-voet links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2254 |
X-voet rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2255 |
X-nek/cervicale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2256 |
X-rug/thoracale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2257 |
X-onderrug/lumbale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2258 |
X-schedel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2259 |
X-neus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2260 |
X-sinussen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2261 |
X-gebit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2262 |
X-kaak/mond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2263 |
CT-bovenarm links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2264 |
CT-bovenarm rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2265 |
CT-bovenbeen links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2266 |
CT-bovenbeen rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2267 |
CT-elleboog links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2268 |
CT-elleboog rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2269 |
CT-enkel links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2270 |
CT-enkel rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2271 |
CT-gebit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2272 |
CT-hand links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2273 |
CT-hand rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2274 |
CT-kaak/mond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2275 |
CT-knie links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2276 |
CT-knie rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2277 |
CT-nek/cervicale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2278 |
CT-neus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2279 |
CT-onderarm links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2280 |
CT-onderarm rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2281 |
CT-onderbeen links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2282 |
CT-onderbeen rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2283 |
CT-onderrug/lumbale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2284 |
CT-pols links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2285 |
CT-pols rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2286 |
CT-rug/thoracale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2287 |
CT-schedel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2288 |
CT-schouder links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2289 |
CT-schouder rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2290 |
CT-sinussen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2291 |
CT-voet links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2292 |
CT-voet rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2293 |
MRI-bovenarm links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2294 |
MRI-bovenarm rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2295 |
MRI-bovenbeen links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2296 |
MRI-bovenbeen rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2297 |
MRI-elleboog links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2298 |
MRI-elleboog rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2299 |
MRI-gebit |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2300 |
MRI-hand links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2301 |
MRI-hand rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2302 |
MRI-kaak/mond |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2303 |
MRI-knie links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2304 |
MRI-knie rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2305 |
MRI-nek/cervicale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2306 |
MRI-neus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2307 |
MRI-onderarm links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2308 |
MRI-onderarm rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2309 |
MRI-onderbeen links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2310 |
MRI-onderbeen rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2311 |
MRI-onderrug/lumbale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2312 |
MRI-pols links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2313 |
MRI-pols rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2314 |
MRI-rug/thoracale wervelkolom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2315 |
MRI-schedel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2316 |
MRI-schouder links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2317 |
MRI-schouder rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2318 |
MRI-sinussen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2319 |
MRI-voet links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2320 |
MRI-voet rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2321 |
X-thorax |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2322 |
X-buik overzicht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2323 |
MRI-thorax |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2324 |
MRI-buik overzicht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2325 |
CT-thorax |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2326 |
CT-buik overzicht |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2327 |
mammografie links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2328 |
mammografie rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2329 |
MRI-mamma links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2330 |
MRI-mamma rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2331 |
X-hand groeivoorspelling |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2332 |
caudografie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2333 |
X-maag |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2334 |
X-slokdarm |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2335 |
X-dunne darm |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2336 |
X-colon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2337 |
intraveneus pyelogram (IVP) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2338 |
compressie echografie been links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2339 |
compressie echografie been rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2340 |
echografie mamma links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2341 |
echografie mamma rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2342 |
echografie lever |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2343 |
echografie galblaas/galwegen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2344 |
echografie nier links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2345 |
echografie nier rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2346 |
echografie prostaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2347 |
echografie scrotum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2348 |
echografie uterus en adnexen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2349 |
echografie uterus zwangerschap |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2350 |
echografie carotiden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2351 |
echografie enkel links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2352 |
echografie enkel rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2353 |
echografie knie links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2354 |
echografie knie rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2355 |
echografie schouder links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2356 |
echografie schouder rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2357 |
echografie elleboog links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2358 |
echografie elleboog rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2359 |
gastroscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2360 |
oesophagoscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2361 |
coloscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2362 |
sigmoidoscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2363 |
anoscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2364 |
cystoscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2365 |
hysteroscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2366 |
colposcopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2367 |
artroscopie knie links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2368 |
artroscopie knie rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2369 |
artroscopie heup links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2370 |
artroscopie heup rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2371 |
artroscopie enkel links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2372 |
artroscopie enkel rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2373 |
artroscopie elleboog links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2374 |
artroscopie elleboog rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2375 |
artroscopie schouder links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2376 |
artroscopie schouder rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2377 |
hoe vaak kortademig in rust (CCQ1) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2378 |
hoe vaak kortademig bij inspanning(CCQ2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2379 |
hoe vaak angst benauwdheidsaanval(CCQ3) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2380 |
hoe vaak neerslachtig door ademh. (CCQ4) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2381 |
hoe vaak gehoest (CCQ5) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2382 |
hoe vaak slijm opgehoest (CCQ6) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2383 |
beperkt bij zware activiteit (CCQ7) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2384 |
beperkt bij matige activiteit (CCQ8) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2385 |
beperkt bij ADL (CCQ9) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2386 |
beperkt bij sociale activiteiten (CCQ10) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2387 |
Strongyloides faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2388 |
mirtazapine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2389 |
desmethylmirtazapine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2390 |
mirtazapine en desmethylmirtazapine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2391 |
X-heup links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2392 |
X-heup rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2393 |
CT-heup links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2394 |
CT-heup rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2395 |
MRI-heup links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2396 |
MRI-heup rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2397 |
X-bekken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2398 |
MRI-bekken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2399 |
gemiddelde symptoomscore COPD (CCQ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2400 |
gem. score functionele beperk.COPD (CCQ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2401 |
gem. score mentale klacht/bep. COPD(CCQ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2402 |
gem. score alle klacht/beperk. COPD(CCQ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2403 |
humaan papillomavirus HPV cervix |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2404 |
Borrelia B. index per totaal as. IgG/IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2405 |
motivatie stoppen met roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2406 |
hoofdbehandelaar astma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2407 |
hoofdbehandelaar COPD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2408 |
gewicht patiënt (thuismeting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2409 |
duodenoscopie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2410 |
X-sacrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2411 |
echografie bovenbuik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2412 |
echografie onderbuik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2413 |
controlebeleid preventie HVZ |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2414 |
reden geen geregelde zorg (prev. HVZ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2415 |
echografie schildklier |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2416 |
echografie halsklieren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2417 |
HIV-1-2-as. p24 ag. combo (AxSYM) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2418 |
hoe vaak drinken van alcohol (FiveShot1) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2419 |
aantal alcoh. dranken op dag (FiveShot2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2420 |
geÎrgerd aan opm. drankgew. (FiveShot3) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2421 |
schuldig over drankgewoonten (FiveShot4) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2422 |
's ochts drinken tegen kater (FiveShot5) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2423 |
totaalscore FiveShot vragnlijst(alcohol) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2424 |
weet wanneer we nu leven (MMSE1) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2425 |
weet waar we nu zijn (MMSE2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2426 |
weet voorwerpen te herhalen (MMSE3) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2427 |
uitvoering rekensom/spellingsopd (MMSE4) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2428 |
weet voorwerpen te herinneren (MMSE5) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2429 |
weet voorwerpen te benoemen (MMSE6) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2430 |
weet zin te herhalen (MMSE7) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2431 |
uitvoering opdracht van papier (MMSE8) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2432 |
uitvoering mondelinge opdracht (MMSE9) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2433 |
kan volledige zin opschrijven (MMSE10) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2434 |
kan figuur natekenen (MMSE11) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2435 |
totaalscore MMSE |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2436 |
gewicht bij QI=25 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2437 |
vergeet steeds welke dag het is (OLD1) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2438 |
vergeet regelm.recente gebeurtenis(OLD2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2439 |
kan mededelingen niet navertellen (OLD3) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2440 |
valt vaak onbewust in herhaling (OLD4) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2441 |
vertelt regelm. hetzelfde verhaal (OLD5) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2442 |
kan reg.niet op bep.woorden komen (OLD6) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2443 |
verliest snel de draad van verhaal(OLD7) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2444 |
heeft vraag niet begrepen (OLD8) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2445 |
heeft moeite gesprek te begrijpen (OLD9) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2446 |
verzint uitvluchten (OLD11) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2447 |
toename afhankelijk gedrag (OLD12) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2448 |
haalt tijden door elkaar (OLD10) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2449 |
termijn follow-up voetonderzoek |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2450 |
opmerkingen diÎtiste (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2451 |
aard bijwerking(en) medicatie (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2452 |
educatie insulinegebruik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2453 |
opmerkingen diabetesverpleegkundige |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2454 |
opmerkingen oogonderzoek (DM2) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2455 |
huidtest graspollenmengsel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2456 |
voedingsvoorlichting (insuline) gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2457 |
leefstijlvoorlichting (insuline) gegeven |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2458 |
huidtest graspollenmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2459 |
huidtest graspollenmengsel ALK |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2460 |
huidtest graspollenmengsel Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2461 |
huidtest graspollenmengsel Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2462 |
huidtest graanpollenmengsel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2463 |
huidtest graanpollenmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2464 |
huidtest graanpollenmengsel Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2465 |
huidtest gras/graanpollenmengsel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2466 |
huidtest gras/graanpollenmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2467 |
huidtest gras/graanpollenmengsel Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2468 |
huidtest gras/graanpollenmengsel Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2469 |
huidtest gras/kruidenmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2470 |
huidtest gras/graan/kruidenmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2471 |
huidtest gras/berkmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2472 |
huidtest gras/bomenmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2473 |
huidtest onkruidmengsel Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2474 |
huidtest plantenvezelsmengsel Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2475 |
huidtest schimmelmengsel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2476 |
huidtest schimmelmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2477 |
huidtest schimmelmengsel Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2478 |
huidtest schimmelmengsel 1 Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2479 |
huidtest schimmelmengsel 2 Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2480 |
huidtest beemdlangbloem (Fest.pratensis) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2481 |
huidtest Engels raaigras(Lolium perenne) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2482 |
huidtest Frans raaigras(Arrhen. elatius) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2483 |
huidtest gerst |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2484 |
huidtest glanshaver (Avena Eliator) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2485 |
huidtest handjesgras (Cynodon dactylon) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2486 |
huidtest haver |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2487 |
huidtest hoog struisgras(Agros. gigante) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2488 |
huidtest Italiaans raaigras(Lolium mufl) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2489 |
huidtest kampgras (Cynosurus cristatus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2490 |
huidtest koolzaad |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2491 |
huidtest kropaar (Dactylis glomerata) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2492 |
huidtest maïs |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2493 |
huidtest reukgras(Anthoxanthum odoratum) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2494 |
huidtest rogge |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2495 |
huidtest tarwe |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2496 |
huidtest timotheegras (Phleum pratense) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2497 |
huidtest veldbeemdgras (Poa pratensis) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2498 |
huidtest vossestaart(Aloprcurus pratens) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2499 |
huidtest witbol (Holcus lanatus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2500 |
huidtest acacia (Robinia pseudoacacia) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2501 |
huidtest berk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2502 |
huidtest beuk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2503 |
huidtest den |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2504 |
huidtest ceder |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2505 |
huidtest eik |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2506 |
huidtest els |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2507 |
huidtest es |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2508 |
huidtest esdoorn |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2509 |
huidtest grove den(pijnboom, pinus sylv) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2510 |
huidtest haagbeuk (Carpinus betulus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2511 |
huidtest hazelaar (Corylus avellana) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2512 |
huidtest iep (olm, ulmus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2513 |
huidtest katwilg (teenwilg, Salix vimin) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2514 |
huidtest liguster |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2515 |
huidtest linde (Tilia) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2516 |
huidtest meidoorn (Crataegus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2517 |
huidtest olijfboom |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2518 |
huidtest plataan |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2519 |
huidtest populier |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2520 |
huidtest ruwe berk(zilverberk, Betula p) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2521 |
huidtest spar |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2522 |
huidtest struikheide (Calluna vulgaris) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2523 |
huidtest tamme kastanje |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2524 |
huidtest vlier (Sambucus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2525 |
huidtest wilde kastanje |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2526 |
huidtest wilg |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2527 |
huidtest witte abeel (Populus alba) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2528 |
huidtest bijvoet (Artemisia vulgaris) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2529 |
huidtest brandnetel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2530 |
huidtest dwergambrosa (Ambrosia elatior) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2531 |
huidtest ragweed (Ambrosia artemisiifo.) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2532 |
huidtest glaskruid (Parietaria off/jud) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2533 |
huidtest guldenroede (Solidago) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2534 |
huidtest jasmijn (Philadelphus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2535 |
huidtest margriet (Leucanthemum) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2536 |
huidtest melganzevoet(Chenopodium album) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2537 |
huidtest paardebloem |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2538 |
huidtest rode klaver(Trifolium pratense) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2539 |
huidtest schapezuring (Rumex acetosella) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2540 |
huidtest smalle weegbree |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2541 |
huidtest veldzuring (Rumex acetosa) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2542 |
huidtest (krul)zuring (Rumex crispus) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2543 |
huidtest Aspergillus clavatus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2544 |
huidtest Alternaria alternata |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2545 |
huidtest Aspergillus flavus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2546 |
huidtest Aspergillus fumigatus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2547 |
huidtest Aspergillus nidulans |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2548 |
huidtest Aspergillus niger |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2549 |
huidtest Aspergillus oryzae |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2550 |
huidtest Aspergillus repens |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2551 |
huidtest Aspergillus versicolor |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2552 |
huidtest Aureobasidium pullulans |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2553 |
huidtest Botrytis cinerea |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2554 |
huidtest Chaetomium globosum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2555 |
huidtest Cladosporium cladosporioides |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2556 |
huidtest Cladosporium fulvum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2557 |
huidtest Cladosporium herbarum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2558 |
huidtest Curvularia lunata |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2559 |
huidtest Epicoccum purpurascens |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2560 |
huidtest Fusarium culmorum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2561 |
huidtest Fusarium moniliforme |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2562 |
huidtest Helminthosporium halodes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2563 |
huidtest Helminthosporium sativum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2564 |
huidtest Merulius (Serpula) lacrymans |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2565 |
huidtest Microsporum canis |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2566 |
huidtest Mucor mucedo |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2567 |
huidtest Mucor racemosus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2568 |
huidtest Neurospora sitophila |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2569 |
huidtest Penicillium brevicompactum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2570 |
huidtest Penicillium chrysogenum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2571 |
huidtest Penicillium commune |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2572 |
huidtest Penicillium digitatum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2573 |
huidtest Penicillium expansum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2574 |
huidtest Penicillium frequentas |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2575 |
huidtest Penicillium notatum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2576 |
huidtest Phoma betea |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2577 |
huidtest Pullularia pullulans |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2578 |
huidtest Rhizopus nigricans |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2579 |
huidtest Rhodotorula rubra |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2580 |
huidtest Saccharomyces cerevisiae |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2581 |
huidtest Stemphylium botryosum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2582 |
huidtest Tricophyton mentagrophytes |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2583 |
huidtest Tricophyton rubrum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2584 |
huidtest Ustilago tritici |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2585 |
huidtest Candida albicans |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2586 |
huidtest Saccharomyces mellis |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2587 |
huidtest kakkerlak |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2588 |
huidtest latex |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2589 |
huidtest gerstemeel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2590 |
huidtest dieren epithelia mengsel 1 Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2591 |
huidtest dieren epithelia mengsel 2 Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2592 |
huidtest dierenharen mengsel 1 Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2593 |
huidtest dierenharen mengsel 2 Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2594 |
huidtest (on)kruidenmengsel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2595 |
huidtest zomerkruidenmengsel HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2596 |
huidtest bomenmengsel 1 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2597 |
huidtest voorjaarsbomen 1 HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2598 |
huidtest bomenmengsel 2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2599 |
huidtest bomenmengsel 3 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2600 |
huidtest voorjaarsbomen ALK |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2601 |
huidtest bomen 1 Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2602 |
huidtest boompollenmengsel 1 Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2603 |
huidtest voorjaarsbomen 2 HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2604 |
huidtest voorjaarsbomen 2 ALK |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2605 |
huidtest bomen 2 Ooms |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2606 |
huidtest boompollenmengsel 2 Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2607 |
huidtest voorjaarsbomen 3 HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2608 |
huidtest boompollenmengsel 3 Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2609 |
huidtest kruidenpollenmengsel 1 Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2610 |
huidtest kruidenpollenmengsel 2 Artu |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2611 |
huidtest zuringmengsel(veld,krul,schape) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2612 |
huidtest Dermatoph.farinae(huisstofmijt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2613 |
huidtest Dermatoph.pteronys(huisstmijt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2614 |
huidtest Acarus Siro (meelmijt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2615 |
huidtest Glycyphagus domestic.(huismijt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2616 |
huidtest Lepidoglyphus destruc(hooimijt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2617 |
huidtest Tyrophagus putrecent(copramijt) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2618 |
huidtest roggemeel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2619 |
huidtest tarwemeel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2620 |
huidtest meelmengsel (gerst,rog,trw) HAL |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2621 |
huidtest cavia epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2622 |
huidtest eend epitheel / eendenveren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2623 |
huidtest gans epitheel / ganzenveren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2624 |
huidtest geit epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2625 |
huidtest hamster epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2626 |
huidtest hond epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2627 |
huidtest kanarie epitheel / kanarieveren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2628 |
huidtest kat epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2629 |
huidtest kip epitheel / kippenveren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2630 |
huidtest koe epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2631 |
huidtest konijn epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2632 |
huidtest muis epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2633 |
huidtest paard epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2634 |
huidtest papegaai epitheel/papegaaiveren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2635 |
huidtest parkiet epitheel / parkietveren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2636 |
huidtest rat epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2637 |
huidtest schaap epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2638 |
huidtest varken epitheel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2639 |
huidtest controlevloeistof |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2640 |
huidtest histamine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2641 |
kristallen, bilirubine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2642 |
kristallen, leucine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2643 |
kristallen, tyrosine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2644 |
kristallen, cystine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2645 |
glycohemoglobine (HbA1c) confirmatietest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2646 |
termijn vervolgconsult (osteoporose) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2647 |
lues anti-treponema pallidum as. |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2648 |
vetvrije massa index (VVMI) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2649 |
echografie aorta abdominalis (AAA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2650 |
echografie blaas |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2651 |
amylase isoenzym S4 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2652 |
calcium gecorrigeeerd (voor albumine) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2653 |
kweek MultiRes.Staf.Aur.(MRSA)huidlaesie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2654 |
kweek MultiRes.Staf.Aur. (MRSA) keel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2655 |
kweek MultiRes.Staf.Aur. (MRSA) neus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2656 |
kweek MultiRes.Staf.Aur.(MRSA) perineum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2657 |
Chlamydia trachomatis uretra (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2658 |
24-uurs bloeddrukmeting |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2659 |
gemiddelde syst. bloeddruk (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2660 |
gemiddelde diast.bloeddruk (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2661 |
hoogste syst. bloeddruk (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2662 |
hoogste diast. bloeddruk (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2663 |
laagste syst. bloeddruk (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2664 |
laagste diast. bloeddruk (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2665 |
perc. bloeddrukdaling nacht(24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2666 |
gemid. syst.bloeddruk nacht(24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2667 |
gemid.diast.bloeddruk nacht(24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2668 |
gemid. syst. bloeddruk dag (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2669 |
gemid.diast.bloeddruk dag (24-u meting) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2670 |
cotinine (nicotine metabolieten) urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2671 |
cotinine (nicotine metabolieten) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2672 |
problemen om slijm weg te hoesten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2673 |
ongewenst gewichtsverlies |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2674 |
gevolgen astma/COPD voor werk |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2675 |
fysieke beperkingen inspanning |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2676 |
verminderde voedingstoestand (COPD) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2677 |
op werk meer klachten (astma) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2678 |
eerder astmamedicatie gehad |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2679 |
effect eerdere astmamedicatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2680 |
zuurstofsaturatie (pulsoximeter) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2681 |
totaalscore OLD |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2682 |
leverancier huidtesten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2683 |
LDL-cholesterol direct |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2684 |
vitamine B3 (nicotinezuur) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2685 |
elastase faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2686 |
methylmalonzuur |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2687 |
methylmalonzuur urine 24u |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2688 |
methylmalonzuur urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2689 |
Bordetella parapertussis (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2690 |
vitamine B12 holo-transcobalamine/actief |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2691 |
vitamine B1 (thiaminemonofosfaat) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2692 |
vitamine B1 (thiaminedifosfaat) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2693 |
vitamine D (25OH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2694 |
vitamine D3 (1,25OH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2695 |
vitamine D2 (1,25OH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2696 |
vitamine D (1,25OH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2697 |
Coxiella Burnetii as. IgM (Q-koorts) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2698 |
Coxiella Burnetii as. IgG (Q-koorts) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2699 |
Coxiella Burnetii as. IgG (Q-krts) titer |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2700 |
Coxiella Burnetii as. IgM (Q-krts) titer |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2701 |
spijtserum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2702 |
spijtplasma |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2703 |
quetiapine (Seroquel) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2704 |
PA-preparaat aard materiaal |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2705 |
PA-preparaat |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2706 |
carbamazepine-diol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2707 |
thyroïd stimulerende immuunglobul. (TSI) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2708 |
quantiferon Gold-TB-test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2709 |
ethanol (alcohol) urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2710 |
4DKL distress-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2711 |
4DKL depressie-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2712 |
4DKL angstscore |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2713 |
4DKL somatisatie-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2714 |
hoofdbehandelaar GGZ |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2715 |
thyrotropin binding inhibitory Ig (TBII) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2716 |
mammografie BI-RADS classificatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2717 |
advies follow-up fundusscreening DM2 |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2718 |
bijzonderheden voedingspatroon |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2719 |
int. prostaat symptoom score (I-PSS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2720 |
6 minuten looptest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2721 |
ernst klachten perifeer art. vaatlijden |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2722 |
ernst klachten decompensatio/hartfalen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2723 |
vaderschapstest DNA mondslijmvlies |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2724 |
rabies serologie kwantitatief |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2725 |
Chlamydia pneumoniae as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2726 |
Legionella as. IgG |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2727 |
Legionella as. IgM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2728 |
Legionella as. IgM kwantitatief |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2729 |
Legionella as. IgG kwantitatief |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2730 |
Legionella as. IgG (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2731 |
Legionella as. IgM (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2732 |
Legionella ag. urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2733 |
lues TPPA |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2734 |
lues treponema pallidum blot |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2735 |
Coxiella Burnetii as. (Q-koorts) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2736 |
Coxiella Burnetii as. (Q-koorts) (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2737 |
Escherischia coli typering faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2738 |
Yersinia enterocolitica typering faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2739 |
MultiRes.SA (MRSA) typering huidlaesie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2740 |
MultiRes.SA (MRSA) typering keel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2741 |
MultiRes.SA (MRSA) typering neus |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2742 |
MultiRes.SA (MRSA) typering perineum |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2743 |
Helicobacter pylori as. IgG kwantitatief |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2744 |
Helicobacter pylori as. IgM kwantitatief |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2745 |
CD4-T lymfocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2746 |
CD8-T lymfocyten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2747 |
vitamine D2 (25OH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2748 |
vitamine D3 (25OH) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2749 |
coproporfyrine I urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2750 |
coproporfyrine III urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2751 |
coproporfyrine III percentage urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2752 |
heptaporfyrinen urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2753 |
hexaporfyrinen urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2754 |
pentaporfyrinen urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2755 |
geschatte gemiddelde glucose (GGG, eAG) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2756 |
occult bloed faeces, immunolog. (iFOBT) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2757 |
ethylglucuronide urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2758 |
ethylglucuronide urine per kreatinine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2759 |
ariprazol (Abilfy) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2760 |
HIV-1 RNA kwantitatief (PCR) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2761 |
longleeftijd |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2762 |
score astma control questionnaire (ACQ) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2763 |
totale dermatoscopie score (TDS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2764 |
asymmetrie, dermatoscopiescore (TDS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2765 |
rand, dermatoscopiescore (TDS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2766 |
kleur, dermatoscopiescore (TDS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2767 |
differentiÎle structuren, dermatosc(TDS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2768 |
toestemming terugkomen op roken |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2769 |
eerste sigaret < 30 min na opstaan |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2770 |
voordelen roken voor patiënt |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2771 |
hulp nodig bij dagelijks functioneren |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2773 |
aantal malen gevallen in afgelopen jaar |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2774 |
eigen gezondheidsbeleving |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2775 |
ervaren belemmering gezondheidsproblemen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2776 |
gehoorproblemen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2777 |
polyfarmacie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2778 |
klachten vergeetachtigheid |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2779 |
slaapproblemen |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2780 |
sombere stemming (anamnese) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2781 |
verlies interesse/plezier (anamnese) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2782 |
angstig gevoel |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2783 |
voldoende sociale contacten |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2784 |
aanvullende geg.anamnese/onderz(ouderen) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2785 |
aanwijzingen kwetsbaarheid (ouderenzorg) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2786 |
aanvullende gegevens evaluatie (ouderen) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2787 |
termijn vervolgconsult (ouderenzorg) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2788 |
vervolgconsult ouderenzorg bij |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2789 |
aanvullende gegevens plan (ouderenzorg) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2790 |
aantal warme maaltijden per week |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2791 |
inschatting calciuminname |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2792 |
inschatting vochtinname |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2793 |
score Groningen Frailty Indicator (GFI) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2794 |
tot.score Mini Nutritional Assessm.(MNA) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2795 |
score IADL schaal (Lawton) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2796 |
score Barthel-index (ADL-functioneren) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2797 |
score Get-up and go-test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2798 |
timed get-up and go-test |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2799 |
score Eldery Mobility Scale (EMS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2800 |
score Clock Drawing |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2801 |
fluisterspraaktest |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2802 |
CIZ-indicatie |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2803 |
zorgzwaartepakket verpl.verzorg.(ZZP VV) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2804 |
adequate medicatie-inname |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2805 |
bezoekt dagopvang |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2806 |
opmerkingen dagopvang |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2807 |
zinvolle dagbesteding |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2808 |
kwetsbaarheid (ouderenzorg) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2809 |
score MiniNutritionalAss (MNA) screening |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2810 |
score Getriatric Depression Scale15(GDS) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2811 |
4DKL angstscore |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2812 |
4DKL depressie-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2813 |
4DKL distress-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2814 |
4DKL somatisatie-score |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2815 |
hoofdbehandelaar CVRM |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2816 |
HbA1c (glycohemoglobine) IFCC |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2817 |
Fletcher index 500/1000/2000 Hz links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2818 |
Fletcher index 500/1000/2000 Hz rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2819 |
gem. gehoorverlies 1000/2000/4000 links |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2820 |
gem. gehoorverlies 1000/2000/4000 rechts |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2821 |
HHb fractie (bloedgasanalyse) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2822 |
HbO2 fractie (bloedgasanalyse) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2823 |
calprotectine faeces |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2824 |
alprazolam |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2825 |
broomperidol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2826 |
citalopram |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2827 |
es-citalopram |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2828 |
gammahydroxyboterzuur (GHB) |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2829 |
levetiracetam |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2830 |
midazolam |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2831 |
paracetamol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2832 |
sertindol |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2833 |
sertraline |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2834 |
sulpiride |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2835 |
phencyclidine (PCP) urine |
2.16.840.1.113883.2.4.4.30.45 |
|
0-L |
2836 |
immature granulocyten |
2.16.840.1.113883.2.4.4.30.45 |
|